All dysplastic lesions of the cervix uteri, vagina or vulva

N14_FEMALE_GENITAL_DYSPLASIA_ALL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072 Hospital discharge: ICD-9 — 6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B Cause of death: ICD-10 — N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072 Cause of death: ICD-9 — 6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B 2 out of 7 registries used, show all original rules.	15899
4. Check minimum number of events None	15899
5. Include endpoints None	15899
6. Filter based on genotype QC (FinnGen only)	14518

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_FEMALE_GENITAL_DYSPLASIA_ALL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072
HD_ICD_9	6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072
COD_ICD_9	6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to All dysplastic lesions of the cervix uteri, vagina or vulva based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	86287	86287	-
Only index persons	84042	84042	-
Unadjusted period prevalence (%)
Whole population	2.47	2.47	-
Only index persons	3.09	3.09	-
Median age at first event (years)
Whole population	-	35.10	-
Only index persons	-	34.95	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14518	14518	-
Unadjusted period prevalence (%)	5.15	5.15	-
Median age at first event (years)	36.27	36.27	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15113: Matched controls
147367

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

312.6

7709

52188

8326

FHL

Batch conization

126.8

307.7

405

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

27.3

307.7

7934

5731

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

116.4

307.7

7384

1200

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

13.0

307.7

8791

14289

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

+∞

307.7

650

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

8.1

307.7

1292

1682

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

241.2

307.7

3530

186

ZXC00

NOMESCO Finland

Use of diathermy

41.5

307.7

542

132

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

28.0

307.7

438

157

8325

FHL

Coagulation, cryo or laser in anesthesia or operating room

71.8

307.7

225

N87.1

ICD-10 Finland

Moderate cervical dysplasia

4472.5

307.7

4276

N87.0

ICD-10 Finland

Mild cervical dysplasia

899.7

307.7

5205

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

34.0

307.7

10679

9755

A63.0

ICD-10 Finland

Anogenital (venereal) warts

6.4

307.7

2030

3502

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

+∞

307.7

475

ULA02

NOMESCO Finland

Kolposcopy

40.8

307.7

11050

9208

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

15.3

307.7

668

444

N89.0

ICD-10 Finland

Mild vaginal dysplasia

6081.1

307.7

609

C539, 6666, 0

ICD-O-3

100.5

307.7

1223

129

N90.0

ICD-10 Finland

Mild vulvar dysplasia

1199.7

307.7

477

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

10.6

307.7

1683

1715

LEB00

NOMESCO Finland

Biopsy of vagina

13.0

307.7

1243

1008

LDA10

NOMESCO Finland

Curettage of cervix uteri

18.9

307.7

4240

2981

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

4766.0

307.7

4937

8070/2-C53.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of cervix uteri

41.1

307.7

350

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

77.6

307.7

523

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

+∞

307.7

394

N89.1

ICD-10 Finland

Moderate vaginal dysplasia

2866.8

306.1

298

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

13.2

294.1

284

213

N90.1

ICD-10 Finland

Moderate vulvar dysplasia

+∞

290.9

281

8474

FHL

Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia

20.7

283.4

218

104

D06.1

ICD-10 Finland

Carcinoma in situ: Exocervix

+∞

269.1

260

N89.2

ICD-10 Finland

Severe vaginal dysplasia, not elsewhere classified

+∞

267.0

258

G01AA10

ATC

clindamycin; vaginal

1.9

246.0

3846

22043

6221C

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]

+∞

240.0

232

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

14.3

217.1

200

138

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

6.0

214.0

386

640

8077/2-C51.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vulva, NOS

419.1

210.9

213

X86

ICPC

Abnormal cervix smear

4.9

204.2

464

949

8077/2-C52.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vagina, NOS

502.2

203.2

204

8411

FHL

Local change laser, coagulation, biopsy or removal

28.7

201.2

137

6221B

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]

+∞

199.6

193

6221A

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI LEVIS]

+∞

196.4

190

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

7.3

194.4

289

391

LFC00

NOMESCO Finland

Partial excision of vulva

17.3

192.0

160

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

269.1

184.4

190

R87.2

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances

23.7

175.9

128

LDC00

NOMESCO Finland

Conisation of cervix uteri using knife

48.6

175.5

104

D06BB04

ATC

podophyllotoxin; topical

2.3

157.3

1308

5836

D06BB10

ATC

imiquimod; topical

2.6

150.4

935

3652

R87.1

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of hormones

26.2

148.1

104

N87

ICD-10 Finland

Dysplasia of cervix uteri

24.8

141.0

101

D07.1

ICD-10 Finland

Carcinoma in situ: Vulva

1362.8

139.5

137

8077/2-C53.1

ICD-O-3

Squamous intraepithelial neoplasia, high grade of exocervix

179.7

138.4

146

R87.0

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of enzymes

21.7

138.0

104

D06.9

ICD-10 Finland

Carcinoma in situ: Cervix, unspecified

+∞

135.3

131

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

122.1

2697

16678

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

117.2

2910

18534

P01AB01

ATC

metronidazole; oral, rectal

1.5

105.3

6783

52864

2331A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Cervix uteri

+∞

105.3

102

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

11.8

104.7

108

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

102.5

5071

37499

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

8.0

88.3

121

149

Z3232

NOMESCO Finland

Midwife

1.6

85.2

2345

15189

Z2221

NOMESCO Finland

Medical doctor

1.5

85.0

4211

30890

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

83.5

907

4463

Z3231

NOMESCO Finland

Registered nurse

1.5

83.2

3368

23729

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

10.0

78.4

X23

ICPC

Fear sexually transm dis female

1.7

75.4

1473

8723

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.6

74.4

2194

14399

N07BA03

ATC

varenicline; oral

2.0

69.5

782

3893

LDB10

NOMESCO Finland

Cryotherapy of cervix uteri

6.3

68.4

116

181

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

6.3

64.7

109

169

TLC02

NOMESCO Finland

Simple extraction of IUD

1.8

64.6

1122

6415

C51.01

ICD-10 Finland

Squamous cell carcinoma of the labium majus

19.2

64.1

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

9.9

64.1

N93.0

ICD-10 Finland

Postcoital and contact bleeding

3.0

60.0

276

918

N76.0

ICD-10 Finland

Acute vaginitis

1.6

59.9

1783

11681

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

9.3

59.3

N90.3

ICD-10 Finland

Dysplasia of vulva, unspecified

199.1

58.5

O34.4

ICD-10 Finland

Maternal care for other abnormalities of cervix

7.1

57.6

120

J02AC01

ATC

fluconazole; systemic

1.3

57.4

7666

64687

R2110

NOMESCO Finland

Giving the first information

1.7

57.3

1251

7606

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.4

56.8

410

1710

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

17.3

55.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

54.4

4778

37924

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

17.9

53.6

SPAT1193

SPAT

Pap smear

1.4

53.1

2391

17003

1390

FHL

Colposcopy

9.0

53.1

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

51.4

2419

17334

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

2.7

47.9

266

980

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

47.6

3928

30759

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

46.8

1129

7024

X92

ICPC

Chlamydia infection genital female

2.4

46.5

336

1402

G01AF01

ATC

metronidazole; vaginal

1.5

45.3

1577

10646

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

44.6

10910

98019

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.3

44.0

358

1572

N89.3

ICD-10 Finland

Dysplasia of vagina, unspecified

146.7

42.3

M03BX02

ATC

tizanidine; oral

1.3

41.7

9497

84104

8111

FHL

Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)

7.7

41.1

7950A

ICD-9 Finland

Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix

10.5

40.5

R87.8

ICD-10 Finland

Abnormal findings in specimens from female genital organs, other abnormal findings

3.8

38.8

118

303

LCH11

NOMESCO Finland

Pharmacologic abortion

1.6

38.7

999

6309

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

38.6

1045

6672

SPAT1308

SPAT

Sexual health counselling

1.3

38.0

2890

22252

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

37.6

1622

11388

J01DB01

ATC

cefalexin; oral

1.3

36.9

12204

112160

8140/2-C53.1

ICD-O-3

Adenocarcinoma in situ, NOS, of exocervix

185.7

36.4

M54.5

ICD-10 Finland

Low back pain

1.3

35.9

5532

46516

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

34.5

11338

103451

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

34.5

5827

49429

8071/2-C51.9

ICD-O-3

Differentiated intraepithelial neoplasia of vulva, NOS

175.9

34.4

J01CA08

ATC

pivmecillinam; oral

1.2

33.7

7797

68337

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

33.5

1157

7777

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

33.4

4541

37559

N02AX02

ATC

tramadol; systemic, rectal

1.2

32.9

4933

41232

X15

ICPC

Vaginal symptom/complaint other

1.6

32.8

910

5839

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

2.8

32.5

160

555

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.8

32.4

458

2456

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

32.0

4454

36892

8140/2-C53.0

ICD-O-3

Adenocarcinoma in situ, NOS, of endocervix

310.0

31.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

30.2

734

4568

N02BE01

ATC

paracetamol; systemic, rectal

1.3

30.0

12998

121241

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

7.5

30.0

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

29.9

1305

9162

8076/3-C53.9

ICD-O-3

Squamous cell carcinoma, microinvasive of cervix uteri

40.1

29.5

N90.4

ICD-10 Finland

Leukoplakia of vulva

3.9

29.4

211

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

9.0

29.1

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

28.7

1989

15049

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

28.2

1311

9309

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

27.9

399

2149

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.7

27.9

559

3314

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

27.8

5730

49264

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

27.6

4390

36759

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

27.1

10697

97821

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

27.1

253

1177

K02.1

ICD-10 Finland

Caries of dentine

1.2

26.7

9082

81774

J05AB01

ATC

aciclovir; systemic

1.3

26.3

3112

25197

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

1.6

26.3

588

3586

ZXC10

NOMESCO Finland

Use of laser

2.1

26.0

234

1073

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

25.9

1515

11161

SPAT1283

SPAT

Restricted health certificate

1.2

25.9

3461

28408

Z71.8

ICD-10 Finland

Other specified counselling

1.2

25.7

5242

44923

N76.6

ICD-10 Finland

Ulceration of vulva

2.3

25.7

195

834

W11

ICPC

Contraception oral

1.3

25.6

1990

15283

SDA03

NOMESCO Finland

Periodontal treatment

1.2

25.5

6273

54704

J01AA02

ATC

doxycycline; systemic

1.2

25.5

10807

99138

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.4

25.2

1539

11412

8339

FHL

Other measure in this category

5.4

25.2

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.7

24.9

510

3042

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

24.8

8054

71953

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

24.7

5583

48261

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

24.6

5709

49470

XLA10, ,

NOMESCO Finland

1.5

23.9

787

5232

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

23.6

9247

83820

SFA20

NOMESCO Finland

Two-surface restoration

1.2

23.2

8927

80732

SFA10

NOMESCO Finland

One-surface restoration

1.2

23.1

8192

73537

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

23.1

4880

41843

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

22.9

13835

130971

ZXE00

NOMESCO Finland

One hour or less

1.2

22.8

5142

44338

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

1.7

22.6

383

2171

Z01.2

ICD-10 Finland

Dental examination

1.2

22.6

7212

64102

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

1.7

22.5

465

2780

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

22.5

6846

60597

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

8.8

22.2

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

22.2

10112

92608

N06AX11

ATC

mirtazapine; oral

1.2

22.1

4590

39260

WX290

NOMESCO Finland

Other blockage of nerve

1.2

22.0

7615

68081

EBA00

NOMESCO Finland

Extraction of tooth

1.2

22.0

4687

40175

N88.2

ICD-10 Finland

Stricture and stenosis of cervix uteri

4.5

21.9

115

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

21.9

5718

49900

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.3

21.9

1398

10424

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

21.9

544

3404

Z72.0

ICD-10 Finland

Tobacco use

1.8

21.7

320

1743

8070/2-C51.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of vulva, NOS

+∞

21.7

N30.0

ICD-10 Finland

Acute cystitis

1.2

21.6

2693

21870

N05CF01

ATC

zopiclone; oral

1.2

21.6

3454

28797

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

21.6

2932

24038

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.3

21.5

1975

15478

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

1.6

21.3

491

3016

J01EA01

ATC

trimethoprim; systemic

1.2

20.4

3836

32455

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.7

20.3

348

1981

J01DA01

ATC

[U] cefalexin

1.2

20.2

8556

77534

M79.6

ICD-10 Finland

Pain in limb

1.2

20.1

6274

55448

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

20.0

3104

25766

R74

ICPC

Upper respiratory infection acute

1.2

20.0

6082

53638

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

19.9

1995

15786

L04AX01

ATC

azathioprine; systemic

1.6

19.8

496

3111

X85

ICPC

Cervical disease NOS

5.8

19.7

D07.2

ICD-10 Finland

Carcinoma in situ: Vagina

+∞

19.6

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

19.6

3249

27144

8112

FHL

Scraping the cervix

5.9

19.6

M01AH05

ATC

etoricoxib; oral

1.2

19.5

8846

80475

C539, 8483, 2

ICD-O-3

195.3

19.4

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

19.3

3204

26761

SPAT1192

SPAT

Gynaecological examination

1.3

19.3

2176

17455

X14

ICPC

Vaginal discharge

1.5

19.2

534

3429

M01AB05

ATC

diclofenac; systemic, rectal

1.2

19.0

8997

82051

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

19.0

2822

23313

ULC02

NOMESCO Finland

Hysteroscopy

1.4

18.9

821

5751

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.5

18.8

620

4123

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

18.8

2088

16712

J01MA02

ATC

ciprofloxacin; systemic

1.2

18.7

4084

34967

R51.80

ICD-10 Finland

Headache

1.2

18.7

2520

20606

N06AB04

ATC

citalopram; systemic

1.2

18.5

2679

22069

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

18.4

2538

20795

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

18.3

377

2254

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.4

18.2

764

5322

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.4

18.0

120

487

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

17.8

8608

78418

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

17.8

578

3835

WX002

NOMESCO Finland

Sedation and analgesia

1.3

17.7

1775

14032

4044, ,

NOMESCO Finland

6.2

17.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

17.7

4523

39211

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

1.7

17.5

347

2055

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

1.7

17.5

331

1937

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

2.2

17.5

138

603

H02AB06

ATC

prednisolone; systemic

1.2

17.4

5884

52130

D19

ICPC

Teeth/gum symptom/complaint

1.2

17.4

4690

40824

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

17.4

6843

61336

P01

ICPC

Feeling anxious/nervous/tense

1.2

17.2

2514

20703

SFA30

NOMESCO Finland

Three-surface restoration

1.2

17.2

5432

47858

A03

ICPC

Fever

1.2

17.1

2684

22261

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

2.3

17.0

131

567

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.5

16.9

527

3467

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

16.9

1394

10757

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.5

16.7

465

2986

8113

FHL

Fractional scraping

1.5

16.7

460

2947

P17

ICPC

Tobacco abuse

2.0

16.7

188

940

6230B

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE MODERATA]

+∞

16.5

Z30.2

ICD-10 Finland

Sterilization

1.3

16.5

1716

13622

C51.9

ICD-10 Finland

Malignant neoplasm: Vulva, unspecified

7.3

16.4

A02BC02

ATC

pantoprazole; systemic

1.2

16.3

8836

80900

Z5132

NOMESCO Finland

Nursing associate professional

2.9

16.2

248

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

16.1

5614

49769

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

16.1

330

1974

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

16.0

2660

22172

J01FF01

ATC

clindamycin; systemic

1.2

16.0

3175

26896

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

2.7

16.0

315

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

15.9

5108

44988

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.5

15.8

570

3860

J05AB11

ATC

valaciclovir; oral

1.2

15.8

1897

15298

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

3.6

15.7

143

N05BA04

ATC

oxazepam; oral

1.2

15.7

3461

29581

D07AD01

ATC

clobetasol; topical

1.2

15.6

1994

16187

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

15.6

3663

31469

LDA96

NOMESCO Finland

Other biopsy of cervix uteri

14.1

15.5

LEB10

NOMESCO Finland

Excision of lesion of vagina

2.7

15.5

309

Z2446

NOMESCO Finland

Social worker

1.4

15.3

674

4737

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.3

15.2

1501

11835

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

15.2

3397

29055

M01AE02

ATC

naproxen; oral, rectal

1.1

15.1

8176

74646

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

10.9

15.0

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.1

14.9

137

638

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

14.8

4191

36521

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

14.7

1072

8133

R87.3

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of substances chiefly nonmedicinal as to source

13.6

14.7

62191

ICD-8 Finland

Other diseases of cervix, Dysplasia portionis uteri

3.0

14.7

199

R05

ICPC

Cough

1.2

14.7

3408

29223

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

14.6

1961

15991

W12

ICPC

Contraception intrauterine

1.2

14.6

2370

19693

N06AX16

ATC

venlafaxine; oral

1.2

14.5

2185

18021

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

14.5

2469

20603

K05.30

ICD-10 Finland

Periodontitis complex

1.3

14.5

1479

11706

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

14.5

978

7345

LFD10

NOMESCO Finland

Vulvectomy and excision of regional lymph nodes

17.9

14.4

F43.0

ICD-10 Finland

Acute stress reaction

1.3

14.4

1177

9066

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

14.4

2970

25211

L03

ICPC

Low back symptom/complaint

1.2

14.4

4139

36087

7020X

ICD-9 Finland

Other dermatoses, Actinic keratosis[DERMATOSES PRAECANCEROSAE ALIAE]

146.4

14.3

N03AX16

ATC

[U] pregabalin

1.2

14.2

2462

20579

A51.3

ICD-10 Finland

Secondary syphilis of skin and mucous membranes

6.0

14.1

Z3226

NOMESCO Finland

Physiotherapist

1.2

14.1

1828

14848

LCD10

NOMESCO Finland

Vaginal hysterectomy

1.5

14.0

420

2742

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.2

14.0

1604

12862

R87

ICD-10 Finland

Abnormal findings in specimens from female genital organs

3.3

13.8

156

D01

ICPC

Abdominal pain/cramps general

1.2

13.8

1770

14363

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

1.4

13.8

545

3759

D82

ICPC

Teeth/gum disease

1.1

13.8

5690

50880

R53

ICD-10 Finland

Malaise and fatigue

1.2

13.7

3517

30380

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

13.7

3972

34633

W14

ICPC

Contraception female other

1.3

13.6

1065

8158

TAC99

NOMESCO Finland

Other blockade for chronic pain

2.7

13.6

262

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.4

13.6

539

3719

R42

ICD-10 Finland

Dizziness and giddiness

1.2

13.6

2475

20772

SDA05

NOMESCO Finland

Very demanding periodontal treatment

1.3

13.5

917

6893

J01FA10

ATC

azithromycin; systemic

1.1

13.5

8819

81241

SPAT1312

SPAT

General health counselling

1.2

13.5

4061

35500

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

13.4

7398

67383

R4110

NOMESCO Finland

Physiotherapy

1.2

13.4

2926

24940

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.2

13.4

2666

22547

Z30.8

ICD-10 Finland

Other contraceptive management

1.4

13.4

551

3828

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

1.6

13.4

316

1959

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.5

13.4

472

3187

N06AB10

ATC

escitalopram; oral

1.2

13.3

3310

28505

N06AX21

ATC

duloxetine; oral

1.2

13.3

1625

13119

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

13.3

995

7580

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

13.3

1045

8013

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

13.2

2912

24832

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

13.2

3367

29052

C07AA05

ATC

propranolol; systemic

1.2

13.0

2940

25125

8327

FHL

Amputation portionis and conization

39.0

13.0

XLD00, ,

SPAT

1.6

13.0

301

1859

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

1.9

12.9

165

864

127

Kela drug reimbursment

Transplant complication

2.1

12.9

124

588

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

12.9

1853

15206

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

12.7

404

2671

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.3

12.7

1243

9790

X16

ICPC

Vulval symptom/complaint

1.6

12.6

259

1552

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

12.6

5276

47133

U02

ICPC

Urinary frequency/urgency

1.2

12.6

1952

16131

D11

ICPC

Diarrhoea

1.2

12.6

1840

15122

N05AH04

ATC

quetiapine; oral

1.2

12.6

2359

19837

N30

ICD-10 Finland

Cystitis

1.2

12.5

1428

11442

SPAT1254

SPAT

Administration of medicine

1.3

12.5

1231

9701

O34.3

ICD-10 Finland

Maternal care for cervical incompetence

2.1

12.4

112

518

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

3.8

12.4

8077/2-C51.1

ICD-O-3

Squamous intraepithelial neoplasia, high grade of labium minus

+∞

12.4

2333B

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]

+∞

12.4

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

1.8

12.4

178

967

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

12.3

1163

9117

A11CC03

ATC

alfacalcidol; systemic

1.9

12.3

158

829

L04AA01

ATC

[U] ciclosporin

2.0

12.3

132

652

SDA12

NOMESCO Finland

Treatment of complicated periodontal disease

1.8

12.2

180

985

AA1AD

NOMESCO Finland

CT of head and brain

1.2

12.2

2302

19361

M25.5

ICD-10 Finland

Pain in joint

1.1

12.2

4810

42780

X91

ICPC

Condylomata acuminata female

2.6

12.1

244

SPAT1263

SPAT

Sampling

1.1

12.0

5410

48518

P01BA02

ATC

hydroxychloroquine; oral

1.3

12.0

975

7509

X29

ICPC

Genital sympt/compl female other

1.6

11.9

248

1494

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

11.8

943

7246

T74.1

ICD-10 Finland

Physical abuse

1.6

11.8

266

1634

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

11.8

1615

13188

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.2

11.7

1894

15707

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

11.6

195

1109

LDC10

NOMESCO Finland

Partial excision of cervix uteri

5.1

11.6

M54

ICD-10 Finland

Dorsalgia

1.2

11.5

1802

14898

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

11.5

2776

23816

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.2

11.5

1215

9651

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.4

11.5

575

4131

8070/3-C51.1

ICD-O-3

Squamous cell carcinoma, NOS, of labium minus

29.3

11.5

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

3.7

11.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

11.5

1643

13471

J01CA04

ATC

amoxicillin; systemic

1.2

11.5

12264

116010

H00.00

ICD-10 Finland

Hordeolum

1.4

11.4

622

4528

R03AC02

ATC

salbutamol; inhalant

1.1

11.4

7972

73366

L04AD02

ATC

tacrolimus; systemic

2.2

11.3

404

L04AX03

ATC

methotrexate; systemic

1.3

11.2

1093

8601

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.2

11.2

1168

9262

N07BB01

ATC

disulfiram; oral

1.5

11.2

322

2088

R21

ICPC

Throat symptom/complaint

1.1

11.2

3733

32788

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

11.1

2891

24936

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

11.1

2387

20283

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

11.1

3225

28044

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

2.8

11.1

194

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

11.0

622

4555

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

11.0

2626

22504

Z00.0

ICD-10 Finland

General medical examination

1.2

10.9

2090

17593

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.3

10.9

839

6417

EMB10

NOMESCO Finland

Tonsillectomy

1.3

10.8

958

7453

H02AB07

ATC

prednisone; oral

1.2

10.8

1352

10934

N88.9

ICD-10 Finland

Noninflammatory disorder of cervix uteri, unspecified

3.6

10.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.3

10.8

964

7510

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

1.7

10.8

195

1133

R87.4

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal immunological findings

5.4

10.8

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

1.8

10.7

141

747

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

10.7

2166

18317

LDC96

NOMESCO Finland

Other excision of cervix uteri

20.9

10.5

8077/2-C53.0

ICD-O-3

Squamous intraepithelial neoplasia, high grade of endocervix

58.5

10.5

8070/3-C53.1

ICD-O-3

Squamous cell carcinoma, NOS, of exocervix

12.6

10.5

K50.8

ICD-10 Finland

Other Crohn disease

1.7

10.4

173

983

UJF32

NOMESCO Finland

Coloscopy

1.2

10.4

2384

20360

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

10.3

483

3438

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

2.5

10.2

243

L12

ICPC

Hand/finger symptom/complaint

1.2

10.1

2194

18650

LFD00

NOMESCO Finland

Vulvectomy

18.3

10.1

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.4

10.0

432

3030

J36

ICD-10 Finland

Peritonsillar abscess

1.4

10.0

427

2989

B02AA02

ATC

tranexamic acid; systemic

1.2

10.0

2564

22075

A12AA04

ATC

calcium carbonate; oral

2.1

10.0

444

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.9

10.0

114

577

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

10.0

2616

22562

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.2

10.0

1890

15889

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

9.9

157

880

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.2

9.9

1243

10054

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

9.9

5067

45649

R02

ICPC

Shortness of breath/dyspnoea

1.2

9.9

1371

11201

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

4.6

9.8

8542/3-C51.9

ICD-O-3

Paget disease, extramammary of vulva, NOS

39.0

9.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.1

9.8

4379

39133

N03AX12

ATC

[U] gabapentin; oral

1.2

9.8

1663

13848

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.1

9.8

2938

25587

L02

ICPC

Back symptom/complaint

1.2

9.8

1470

12106

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

3.5

9.7

R06.0

ICD-10 Finland

Dyspnoea

1.2

9.7

2735

23707

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.3

9.7

657

4943

KMAK, ,

NOMESCO Finland

1.1

9.6

7817

72227

L08

ICPC

Shoulder symptom/complaint

1.2

9.6

2591

22381

M77.1

ICD-10 Finland

Lateral epicondylitis

1.2

9.6

1205

9750

C53.0

ICD-10 Finland

Malignant neoplasm: Endocervix

9.3

9.6

L43.8

ICD-10 Finland

Other lichen planus

1.7

9.5

151

847

LX1A3

NOMESCO Finland

Gynaecological cytology evaluation

5.0

9.5

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

7.2

9.5

SPAT1240

SPAT

Therapeutic discussion

1.2

9.5

1637

13650

TK800

NOMESCO Finland

Hemodialysis

1.9

9.5

115

595

A02BC05

ATC

esomeprazole; systemic

1.1

9.4

4892

44075

L04AA06

ATC

mycophenolic acid; systemic

1.7

9.4

169

982

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

4.4

9.4

S01.51

ICD-10 Finland

Open wound on lip

1.7

9.4

159

910

8070/3-C52.9

ICD-O-3

Squamous cell carcinoma, NOS, of vagina, NOS

14.6

9.4

6230A

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE LEVIS]

14.6

9.4

8010/2-C53.9

ICD-O-3

Carcinoma in situ, NOS, of cervix uteri

97.6

9.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.1

9.3

2804

24412

D06.7

ICD-10 Finland

Carcinoma in situ: Other parts of cervix

+∞

9.3

J01FA06

ATC

roxithromycin; oral

1.1

9.3

5002

45159

P76

ICPC

Depressive disorder

1.2

9.3

1087

8733

U01

ICPC

Dysuria/painful urination

1.2

9.3

1077

8645

A56.2

ICD-10 Finland

Chlamydial infection of genitourinary tract, unspecified

2.3

9.2

267

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.5

9.2

214

S18

ICPC

Laceration/cut

1.1

9.2

5002

45182

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.1

9.2

3784

33625

G01AX03

ATC

policresulen; vaginal

1.9

9.1

114

595

L01

ICPC

Neck symptom/complaint

1.2

9.1

2338

20121

LCD30

NOMESCO Finland

Radical hysterectomy

3.4

9.1

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.2

9.1

2218

19022

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.1

9.0

2875

25121

C52.91

ICD-10 Finland

Squamous cell carcinoma of the vagina

13.3

9.0

N94.1

ICD-10 Finland

Dyspareunia

1.5

9.0

266

1739

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.2

9.0

2254

19362

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

9.0

367

2552

N02AA05

ATC

oxycodone; systemic

1.2

9.0

1179

9583

E0000UV, ,

ATC

1.1

9.0

5661

51531

F32.1

ICD-10 Finland

Moderate depressive episode

1.2

8.9

1020

8170

G44.2

ICD-10 Finland

Tension-type headache

1.2

8.9

2096

17914

LDD00

NOMESCO Finland

Suture of cervix uteri

4.6

8.9

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

8.9

418

2977

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

8.9

2432

21024

P74

ICPC

Anxiety disorder/anxiety state

1.3

8.8

743

5748

N05CF02

ATC

zolpidem; oral

1.2

8.8

2184

18741

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.2

8.8

1059

8528

N06AB06

ATC

sertraline; oral

1.2

8.8

1614

13523

09992

ICD-8 Finland

Other veneral disease, Condyloma acuminatum

2.9

8.8

130

S06.0

ICD-10 Finland

Concussion

1.2

8.8

1132

9182

F43.00

ICD-10 Finland

Acute stress reaction mild

1.4

8.8

420

3001

M79.1

ICD-10 Finland

Myalgia

1.2

8.8

2157

18502

6228X

ICD-9 Finland

Noninflammatory disorders of cervix, Other specified noninflammatory disorders of cervix

4.9

8.8

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.2

8.7

1495

12451

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

8.7

835

6559

N05BA01

ATC

diazepam; systemic, rectal

1.2

8.7

1206

9850

0, ,

NOMESCO Finland

4.3

8.7

O04.1

ICD-10 Finland

Medical abortion, incomplete, complicated by delayed or excessive haemorrhage

1.7

8.7

163

960

A02BC03

ATC

lansoprazole; oral

1.1

8.6

2882

25250

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.3

8.6

613

4647

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

8.5

318

2176

LEC00

NOMESCO Finland

Partial excision of vagina

4.8

8.5

G01AF04

ATC

miconazole; vaginal

1.3

8.5

697

5377

K30

ICD-10 Finland

Functional dyspepsia

1.2

8.5

1472

12274

OAA64, ,

SPAT

1.3

8.5

784

6135

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.2

8.5

856

6768

SPAT1153

SPAT

Removal of sutures

1.1

8.5

2927

25702

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.3

8.5

716

5545

WF002

NOMESCO Finland

Radical radiotherapy

1.5

8.4

251

1645

ZXD20

NOMESCO Finland

Day surgery

1.2

8.4

1365

11316

F32

ICD-10 Finland

Depressive episode

1.2

8.4

861

6819

Z01.8

ICD-10 Finland

Other specified special examinations

1.1

8.4

2647

23105

ZX120

NOMESCO Finland

Intravenous

1.2

8.4

842

6655

C539, 8085, 3

ICD-O-3

8.7

8.4

D06

ICPC

Abdominal pain localized other

1.2

8.3

1228

10093

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

8.3

2017

17279

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.2

8.3

1388

11538

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.2

8.3

1854

15786

T810, N872,

ICD-10 Finland

+∞

8.3

6230C

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE GRAVIS]

+∞

8.3

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

1.4

8.2

288

1949

JN3AD

NOMESCO Finland

Abdominal CT examination

1.2

8.2

1190

9763

SPAT1272

SPAT

Drug screening

2.5

8.2

197

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

3.2

8.2

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.8

8.2

108

575

G03CA04

ATC

estriol; systemic, vaginal

1.4

8.2

389

2778

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.2

8.2

1028

8318

M79.7

ICD-10 Finland

Fibromyalgia

1.3

8.2

553

4161

LEB20

NOMESCO Finland

Marsupialisation of vaginal cyst

3.9

8.2

LFC96

NOMESCO Finland

Other partial excision of vulva or perineum

10.5

8.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.1

8.1

3578

31879

V03AE02

ATC

sevelamer; oral

2.8

8.1

131

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.1

8.1

2516

21932

D06BB03

ATC

aciclovir; topical

1.3

8.1

542

4074

N63

ICD-10 Finland

Unspecified lump in breast

1.2

8.1

1163

9536

N06AX12

ATC

bupropion; oral

1.2

8.0

1173

9630

ZX095

NOMESCO Finland

Combined chemoradiotherapy

2.5

8.0

182

Z94.0

ICD-10 Finland

Kidney transplant status

2.0

8.0

382

N97.2

ICD-10 Finland

Female infertility of uterine origin

3.0

8.0

106

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.2

7.9

1332

11075

N39.3

ICD-10 Finland

Stress incontinence

1.2

7.9

954

7686

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.1

7.9

5753

52648

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

7.9

568

4309

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

1.7

7.9

150

887

XQ900

NOMESCO Finland

Photography of physically assaulted person

9.8

7.9

SFA00

NOMESCO Finland

Small restoration

1.2

7.9

1714

14563

R95

ICPC

Chron obstructive pulmonary disease

1.7

7.9

123

690

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.4

7.9

284

1935

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.5

7.8

254

1695

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.2

7.8

956

7715

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.8

4766

43218

ZXE10

NOMESCO Finland

More than one and less than three hours

1.1

7.8

3770

33758

P03

ICPC

Feeling depressed

1.2

7.8

1689

14343

D07AC01

ATC

betamethasone; topical

1.1

7.8

4326

39040

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.4

7.7

371

2654

D73

ICPC

Gastroenteritis presumed infection

1.3

7.7

559

4246

N01

ICPC

Headache

1.2

7.7

1709

14536

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.5

7.7

264

1781

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

1.4

7.7

350

2483

LX1A3, ,

SPAT

2.5

7.7

186

B86

ICD-10 Finland

Scabies

1.4

7.7

350

2485

8140/3-C53.0

ICD-O-3

Adenocarcinoma, NOS, of endocervix

8.2

7.7

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.2

7.6

933

7529

K10.3

ICD-10 Finland

Alveolitis of jaws

1.3

7.6

676

5272

J20

ICD-10 Finland

Acute bronchitis

1.2

7.6

1307

10895

8511

FHL

Cervical dilation and drainage with suction

1.3

7.6

448

3312

ZXD05

NOMESCO Finland

Urgent procedure

1.1

7.6

3861

34670

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.5

7.6

258

1740

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.2

7.5

273

TK810

NOMESCO Finland

Hemofiltration

2.9

7.5

115

P01AB02

ATC

tinidazole; oral, rectal

1.4

7.5

288

1984

S22.3

ICD-10 Finland

Fracture of rib

1.3

7.5

491

3680

D10

ICPC

Vomiting

1.2

7.5

955

7739

Z94.4

ICD-10 Finland

Liver transplant status

2.9

7.5

110

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

3.9

7.5

JAH01

NOMESCO Finland

Laparoscopy

1.3

7.5

641

4975

N81.0

ICD-10 Finland

Female urethrocele

3.0

7.5

105

RS220, ,

NOMESCO Finland

1.7

7.5

116

650

X13

ICPC

Postcoital bleeding

2.1

7.5

287

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.4

7.4

346

2464

H00.1

ICD-10 Finland

Chalazion

1.3

7.4

430

3167

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

1.4

7.4

379

2739

WX402

NOMESCO Finland

General anaesthesia

1.1

7.4

2755

24277

UKC02

NOMESCO Finland

Cystoscopy

1.2

7.4

820

6549

6160A

ICD-9 Finland

Inflammatory disease of cervix, vagina and vulva, Cervicitis and endocervicitis

3.1

7.4

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

2.6

7.4

149

O47.9

ICD-10 Finland

False labour, unspecified

1.4

7.4

322

2269

C53.10

ICD-10 Finland

Malignant tumor of the exocervix without histology

8.6

7.4

K03.00

ICD-10 Finland

Approximal wear

1.2

7.4

974

7922

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.3

7.4

437

3231

ZXA10

NOMESCO Finland

Bilateral

1.2

7.4

1630

13864

N17

ICPC

Vertigo/dizziness

1.2

7.4

1259

10486

O46.9

ICD-10 Finland

Antepartum haemorrhage, unspecified

1.4

7.3

313

2200

X84

ICPC

Vaginitis/vulvitis NOS

1.6

7.3

146

876

S71

ICPC

Herpes simplex

1.7

7.3

125

721

N86

ICD-10 Finland

Erosion and ectropion of cervix uteri

2.1

7.2

278

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.4

7.2

333

2369

8077/2-C51.8

ICD-O-3

Squamous intraepithelial neoplasia, high grade of overlapping lesion of vulva

+∞

7.2

A05

ICPC

Feeling ill

1.2

7.2

732

5795

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

1.3

7.2

426

3150

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

3.1

7.2

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.1

7.1

2266

19770

F43.01

ICD-10 Finland

Acute stress reaction moderate

1.4

7.1

287

1996

ZX108

NOMESCO Finland

Inhalation

2.3

7.1

205

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.5

7.1

244

1648

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.3

7.1

471

3539

A07EC02

ATC

mesalazine; oral, rectal

1.3

7.1

531

4054

OAA65, ,

SPAT

1.1

7.1

3750

33718

SPAT1265

SPAT

Breathalyser

2.0

7.1

326

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

1.6

7.0

169

1060

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.2

7.0

936

7620

U07

ICPC

Urine symptom/complaint other

1.2

7.0

794

6359

LDW96

NOMESCO Finland

Other operation on cervix uteri

3.5

7.0

SBA00

NOMESCO Finland

Microbiological examinations

1.5

7.0

231

1550

B01AB10

ATC

tinzaparin; parenteral

1.2

7.0

1085

8962

LDA00

NOMESCO Finland

Dilatation of cervix uteri

1.7

6.9

115

657

SPAT1058

SPAT

PEF monitoring instruction

1.2

6.9

709

5618

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

1.8

6.9

514

SGC10

NOMESCO Finland

Pulp capping

1.2

6.9

1195

9966

EB1AA, ,

SPAT

1.2

6.9

740

5895

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.4

6.9

305

2157

SPAT1301

SPAT

No procedures

1.1

6.9

3371

30177

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

6.9

568

4391

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

6.9

1363

11493

Z30

ICD-10 Finland

Contraceptive management

1.3

6.9

436

3257

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

0.8

6.8

853

9975

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.2

6.8

722

5741

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.1

6.8

1965

17036

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.3

6.8

561

4338

C03CA01

ATC

furosemide; systemic

1.2

6.8

1552

13233

8070/3-C53.0

ICD-O-3

Squamous cell carcinoma, NOS, of endocervix

13.4

6.8

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

1.6

6.8

155

962

G01AE10

ATC

combinations of sulfonamides; vaginal

2.6

6.7

145

HMAK, ,

NOMESCO Finland

1.2

6.7

1532

13057

E000006, ,

ATC

1.2

6.7

699

5552

R07.0

ICD-10 Finland

Pain in throat

1.2

6.7

1068

8843

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

6.7

391

2889

ZYC01

NOMESCO Finland

Remote contact by phone

1.2

6.7

674

5336

F41

ICD-10 Finland

Other anxiety disorders

1.4

6.6

281

1976

TUPKY, ,

NOMESCO Finland

1.8

6.6

508

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.2

6.6

970

7977

ZXC96

NOMESCO Finland

Robot assisted procedure

1.7

6.6

112

646

WZA00

NOMESCO Finland

Concise certificate

1.2

6.5

776

6247

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.1

6.5

1750

15089

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.2

6.5

823

6665

ZY010

NOMESCO Finland

Hospital outpatient

1.2

6.5

637

5022

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.3

6.5

345

2511

W60

ICPC

Pregnancy, Result test/procedure

1.8

6.5

439

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.3

6.5

342

2487

ZXA00

NOMESCO Finland

Right side

1.1

6.5

2120

18522

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

4.1

6.5

L04AA05

ATC

[U] tacrolimus

6.2

6.5

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.5

6.5

204

1357

Z72.1

ICD-10 Finland

Alcohol use

1.8

6.5

447

TLE30

NOMESCO Finland

Tamponation of vagina

2.9

6.4

SPAT1310

SPAT

Counselling related to known health issue

1.1

6.4

3635

32775

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.1

6.4

3639

32816

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.4

6.4

223

1513

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.3

6.4

373

2755

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.1

6.4

2300

20218

N06AB03

ATC

fluoxetine; oral

1.2

6.4

1429

12169

K50.1

ICD-10 Finland

Crohn disease of large intestine

1.6

6.3

123

734

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.2

6.3

961

7922

N03AX09

ATC

lamotrigine; oral

1.2

6.3

694

5543

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.1

6.3

2981

26619

N64.4

ICD-10 Finland

Mastodynia

1.2

6.3

602

4737

C52.90

ICD-10 Finland

Malignant neoplasm of vagina without histologic examination

13.9

6.3

D06

ICD-10 Finland

Carcinoma in situ of cervix uteri

5.5

6.3

L13

ICPC

Hip symptom/complaint

1.1

6.3

1972

17186

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.1

6.3

2853

25419

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

3.4

6.3

A04

ICPC

Weakness/tiredness general

1.1

6.3

1904

16559

ZXA05

NOMESCO Finland

Left side

1.1

6.3

1955

17032

6440A

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]

1.4

6.2

229

1569

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.1

6.2

1980

17268

L82

ICD-10 Finland

Seborrhoeic keratosis

1.1

6.2

1814

15732

R51

ICD-10 Finland

Headache

1.2

6.2

858

7012

D02

ICPC

Abdominal pain epigastric

1.2

6.2

773

6254

8070/2-C53.1

ICD-O-3

Squamous cell carcinoma in situ, NOS, of exocervix

+∞

6.2

G04BD12

ATC

mirabegron; oral

1.2

6.2

812

6605

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.4

6.2

230

1580

K04.0

ICD-10 Finland

Pulpitis

1.2

6.2

1277

10805

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

3.8

6.2

J01MA06

ATC

norfloxacin; oral

1.2

6.2

1441

12306

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

3.4

6.2

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.2

6.2

914

7522

W83

ICPC

Abortion induced

1.6

6.1

139

862

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.4

6.1

164

Z97.5

ICD-10 Finland

Presence of (intrauterine) contraceptive device

1.4

6.1

289

2068

M54.2

ICD-10 Finland

Cervicalgia

1.2

6.1

981

8128

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.4

6.1

207

1398

H57.1

ICD-10 Finland

Ocular pain

1.3

6.1

527

4100

OAA70, ,

SPAT

1.3

6.1

354

2615

X08

ICPC

Intermenstrual bleeding

1.4

6.1

208

1407

8513

FHL

Softening of cervix with abortifacient or laminars and associated surgical emptying of the uterus

1.3

6.1

315

2288

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

1.3

6.1

506

3921

SPAT1260

SPAT

Consultation of another employee

1.1

6.1

1796

15595

Y07

ICD-10 Finland

Other maltreatment

2.0

6.0

299

EMAK, ,

NOMESCO Finland

1.3

6.0

387

2899

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.2

6.0

801

6524

G01AF05

ATC

econazole; vaginal

1.2

6.0

1206

10179

L01AA01

ATC

cyclophosphamide; systemic

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

946

565

17.35

307.65

2.4

1.4

—

(3025130) Human papilloma virus identified in Specimen

3156

3246

11.72

307.65

2.5

1.4

—

(40768804) Tissue Pathology biopsy report

8858

57131

2.24

307.65

2.7

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

3487

8178

5.10

307.65

2.3

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4842

31130

1.76

207.15

2.6

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4440

28099

1.77

199.04

2.4

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3392

22215

1.63

123.12

2.2

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2852

17956

1.68

120.52

2.0

1.8

—

(4035726) Immunohistochemistry procedure

1735

9543

1.87

116.70

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

153

263

5.72

81.73

1.7

2.3

6.05

2.49

ug/l

0.56

104

166

(46235355) HIV 1 and 2 tests - Meaningful Use set

5284

44037

1.26

37.50

2.3

2.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

10860

98921

1.25

31.55

4.6

4.2

9.89

10.05

mm/h

0.82

10351

94268

(3031040) Bacteria [#/volume] in Urine by Automated count

9969

90056

1.23

30.75

4.7

4.2

1867.33

2032.72

e6/l

0.08

970

(3009261) Glucose [Presence] in Urine by Test strip

8401

74590

1.22

30.58

3.9

3.6

0.01

0.21

estimate

1.16

1687

15246

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2304

17704

1.32

29.88

2.9

2.6

4.81

5.01

e6/l

0.27

1067

7942

(3035350) Ketones [Presence] in Urine by Test strip

8339

74093

1.22

29.71

3.8

3.6

8.08

3.38

estimate

1.13

1762

15613

(3037467) Urinalysis macro (dipstick) panel - Urine

10267

93197

1.23

29.46

4.7

4.3

3.33

6.91

0.34

104

(3002256) Pathology report gross observation

2360

18228

1.31

29.45

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

8255

73327

1.22

29.28

3.8

3.6

0.00

estimate

0.31

1720

15424

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2484

19334

1.30

29.26

2.7

2.5

1.08

1.17

e6/l

0.40

1249

9581

(3018095) Leukocytes [#/volume] in Urine

5445

46510

1.22

28.42

4.0

3.5

57.17

76.71

e6/l

2.99

3613

30283

(3002582) Erythrocytes [#/volume] in Urine

4422

36979

1.23

28.31

3.3

2.9

37.09

59.42

e6/l

1.81

3287

27374

(36304419) Bacteria [Presence] in Urine

3755

31030

1.24

26.50

3.2

2.7

0.69

195.36

estimate

—

(3030467) Casts [#/volume] in Urine by Automated count

3848

31883

1.24

26.49

3.2

2.8

0.31

0.32

e6/l

0.09

2726

22523

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10443

95394

1.22

26.09

8.1

7.4

72.35

73.79

u/l

3.97

9941

91121

(3001604) Monocytes [#/volume] in Blood

7711

68511

1.20

25.64

6.8

6.1

0.53

e9/l

0.18

6848

60488

(3006315) Basophils [#/volume] in Blood

7721

68611

1.20

25.62

6.8

6.1

0.04

e9/l

0.32

6848

60476

(3017143) Hepatitis C virus Ab [Presence] in Serum

2709

21746

1.26

24.44

1.7

1.6

—

(3013115) Eosinophils [#/volume] in Blood

7941

70988

1.19

23.86

7.0

6.3

0.18

e9/l

0.42

7196

63613

(3019198) Lymphocytes [#/volume] in Blood

7868

70333

1.19

23.47

6.8

6.1

1.98

1.96

e9/l

0.63

7181

63455

(3013650) Neutrophils [#/volume] in Blood by Automated count

8464

76383

1.18

21.83

9.4

9.0

3.97

3.95

e9/l

0.28

7450

67234

(3022096) Basophils/Leukocytes in Blood

7028

62453

1.18

21.74

7.0

6.2

0.69

0.70

0.67

6609

58876

(3011397) Hemoglobin [Presence] in Urine by Test strip

3888

32783

1.21

21.68

3.7

3.5

0.64

0.50

0.17

220

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

13104

123305

1.27

21.39

11.9

10.8

90.72

90.35

ml/min/173m2

1.48

11961

112307

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1285

9501

1.35

21.31

1.6

1.5

—

(3006504) Eosinophils/Leukocytes in Blood

7027

62529

1.18

21.14

6.9

6.1

2.73

2.77

1.03

6622

59129

(3019069) Monocytes/Leukocytes in Blood

7036

62629

1.18

21.05

7.0

6.2

8.18

8.19

0.05

6644

59326

(3018010) Neutrophils/Leukocytes in Blood

7143

63818

1.17

20.00

6.7

6.0

56.39

56.43

0.12

6855

61394

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13883

131810

1.33

19.80

13.8

12.2

19.36

19.15

mg/l

0.32

11347

106282

(3002030) Lymphocytes/Leukocytes in Blood

7240

64842

1.17

19.43

6.8

6.1

29.66

0.00

6912

61985

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7093

63463

1.17

19.16

5.9

5.7

9.32

9.71

umol/l

3.92

6731

60241

(3045414) Leukocytes [Presence] in Urine

1591

12298

1.29

19.13

2.0

0.03

0.04

estimate

0.09

347

2768

(3015736) pH of Urine

6642

59177

1.17

18.79

3.4

3.2

6.25

6.24

0.25

3730

33975

(3021589) Normoblasts [#/volume] in Blood

6662

59445

1.17

18.30

10.2

9.7

0.00

e9/l

2.96

5463

48543

(3019550) Sodium [Moles/volume] in Serum or Plasma

13460

127524

1.27

17.56

13.4

12.2

139.56

139.62

mmol/l

2.47

13228

125064

(3029634) Reagin Ab [Titer] in Serum by VDRL

360

2156

1.64

17.40

1.6

1.5

1.33

4.42

titre

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

13477

127748

1.27

17.20

13.6

12.3

3.90

mmol/l

0.22

13220

125004

(3033658) Prothrombin time (PT) actual/Normal

3582

30534

1.19

16.95

4.0

3.5

96.88

97.78

1.57

3487

29678

(3044640) Blood type and Crossmatch panel - Blood

5004

43861

1.17

16.86

2.2

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3770

32367

1.18

16.29

2.2

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6303

56402

1.15

15.79

6.5

6.0

1.22

mmol/l

1.37

5532

49055

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5596

49665

1.16

15.66

6.0

5.4

1.22

mmol/l

0.79

5217

46401

(3000850) Epithelial cells [#/volume] in Urine

2985

25211

1.19

15.48

2.8

2.5

8.93

8.35

e6/l

0.57

2686

22740

(3014051) Protein [Presence] in Urine by Test strip

4834

42502

1.16

15.24

2.9

2.7

0.10

0.04

0.54

582

(3019832) Treponema pallidum Ab [Presence] in Serum

3627

31189

1.18

15.18

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5789

51586

1.15

15.17

4.9

4.4

36.92

36.89

g/l

0.17

5500

48686

(3026782) Osmolality of Urine

2537

21149

1.20

15.15

3.0

2.6

502.64

510.86

mosm/kgh2o

1.07

2230

18485

(3007853) Bacteria identified in Skin by Aerobe culture

1850

14987

1.23

14.70

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2151

17758

1.21

14.14

1.8

1.6

1.38

1.33

2.61

1917

16055

(3029937) Albumin [Presence] in Urine by Test strip

4447

39099

1.15

13.66

4.0

3.7

0.00

estimate

0.05

1687

14913

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10488

97825

1.15

13.13

3.2

3.0

34.73

34.25

u/l

0.30

10082

93957

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1268

9980

1.26

13.02

1.8

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

14293

137001

1.32

12.93

15.6

14.1

66.82

66.53

umol/l

0.86

14165

135717

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7234

65921

1.13

12.75

2.7

2.6

—

estimate

—

(3048689) Calprotectin [Mass/mass] in Stool

2730

23230

1.18

12.67

2.6

2.5

105.21

100.20

ug/g

0.36

2160

18370

(3025941) Bacteria identified in Stool by Culture

1153

9007

1.27

12.60

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3779

33006

1.16

12.49

1.4

33.87

27.55

iu/ml

0.32

1144

9975

(40758558) Short blood count panel - Blood

4385

38726

1.15

12.37

6.1

5.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3491

30337

1.16

12.34

1.4

1.3

9.32

9.24

u/ml

0.03

1430

13027

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1769

14527

1.21

12.18

2.3

4310.07

6203.86

u/l

2.07

691

6109

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

422

2.23

12.12

1.4

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3911

34304

1.15

12.12

1.4

2.15

2.13

g/l

0.43

2475

22551

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4345

38481

1.14

11.59

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4491

39876

1.14

11.51

2.6

2.5

54.75

73.75

u/l

0.67

4202

37236

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1507

12248

1.22

11.49

2.6

2.4

37.26

38.23

u/l

0.12

1260

10362

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1755

14486

1.21

11.42

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

2762

23741

1.16

11.13

1.5

1.4

531.44

555.08

titre

0.28

612

5063

(44816559) Phosphatidylethanol [Mass/volume] in Blood

756

5704

1.31

10.86

1.7

1.6

0.27

0.28

mg/l

0.16

346

2239

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14300

137339

1.28

10.59

11.4

10.4

23.72

23.90

u/l

0.39

14040

134539

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6238

56777

1.12

10.37

3.7

3.4

0.46

0.28

estimate

0.21

1418

12871

(3022145) Colonoscopy Study observation

1754

14624

1.19

10.18

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4581

40995

1.13

10.06

1.4

1.46

1.39

u/ml

0.16

1391

12404

(3018418) pH of Serum or Plasma

3857

34179

1.13

9.88

4.3

3.8

7.40

0.10

2743

23779

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5657

51300

1.12

9.87

2.0

1.9

99.10

99.39

pmol/l

0.18

3091

27491

(3045424) Erythrocytes [Presence] in Urine

806

6233

1.28

9.60

2.0

0.02

0.06

estimate

0.75

310

2295

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

210

2.56

9.58

1.1

—

(3044889) 12 lead EKG panel

8957

83402

1.12

9.55

3.2

3.1

0.60

22.66

—

109

(3015377) Calcium [Moles/volume] in Serum or Plasma

4753

42768

1.12

9.36

3.2

2.35

mmol/l

0.29

4393

39724

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

784

6063

1.28

9.34

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3572

31597

1.13

9.32

1.6

20.87

20.64

nmol/l

0.44

3153

27908

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12172

115471

1.14

9.30

5.1

5.0

14.34

pmol/l

0.09

11572

109667

(3000991) Gas panel - Venous blood

945

7475

1.25

9.29

9.2

8.3

—

(3028707) Methadone [Presence] in Urine by Screen method

523

3837

1.34

9.20

3.0

2.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

596

4462

1.31

9.11

1.6

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13421

128303

1.18

8.95

6.1

5.9

1.69

1.74

mu/l

4.07

12852

123046

(3023511) Choriogonadotropin [Units/volume] in Urine

916

7262

1.24

8.84

1.4

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12787

121851

1.15

8.61

4.2

5.59

5.62

mmol/l

2.27

12113

115581

(3016879) Cocaine [Presence] in Urine

1035

8346

1.22

8.52

2.4

1.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

688

5298

1.28

8.51

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

656

5023

1.29

8.49

4.8

3.9

24.33

24.35

mmol/l

0.06

647

4960

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5102

46282

1.11

8.48

3.5

3.1

29.75

29.28

u/l

0.18

4863

44157

(3019150) Specific gravity of Urine by Refractometry

3647

32478

1.13

8.39

3.8

3.6

1.02

1.21

kg/l

1.34

2371

20971

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1746

14795

1.17

8.30

2.8

2.4

5.80

6.33

umol/l

0.88

1474

12491

(3022621) pH of Urine by Test strip

1376

11434

1.19

8.26

2.3

6.13

6.17

0.87

847

7025

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1420

11848

1.19

8.13

2.5

3.0

39.39

41.51

u/ml

0.08

1379

11488

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1917

16389

1.16

8.11

1.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

1108

9081

1.20

7.74

2.4

1.9

—

(3027008) Opiates [Presence] in Urine

1110

9108

1.20

7.66

2.2

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

905

7279

1.23

7.66

2.6

2.0

10.46

7.09

iu/ml

1.73

247

1752

(3028300) Cannabinoids [Presence] in Urine

1113

9137

1.20

7.64

2.4

1.9

—

(3042936) Bacteria identified in Isolate by Culture

1860

15939

1.16

7.61

2.0

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3814

34230

1.12

7.53

2.3

2.57

2.61

mg/l

0.58

3313

29959

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2562

22472

1.13

7.45

2.4

2.5

2.42

mmol/l

0.12

2257

20205

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3668

32868

1.12

7.43

2.0

163.79

142.24

u/l

0.64

3514

31314

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

969

7872

1.21

7.43

1.8

1.6

—

(3032080) INR in Blood by Coagulation assay

4952

45086

1.11

7.42

8.4

7.9

1.10

inr

0.12

4051

36999

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

271

1863

1.43

7.18

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

271

1863

1.43

7.18

1.2

—

(3000494) Fungus identified in Specimen by Culture

1819

15627

1.15

7.18

1.5

1.4

—

(4198724) Urine methamphetamine measurement

124

717

1.69

7.15

4.1

2.1

—

(3002032) Base excess in Venous blood by calculation

988

8079

1.21

7.09

4.2

3.6

1.92

1.78

mmol/l

0.63

867

7099

(3027944) Amphetamines [Presence] in Urine

1093

9023

1.20

7.07

2.3

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1317

11054

1.18

7.03

1.8

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1017

8352

1.20

6.97

4.2

3.6

5.87

5.81

kpa

1.17

992

8132

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1369

11536

1.17

6.96

1.7

—

(3035941) MCH [Entitic mass]

14882

144156

1.44

6.84

20.9

19.0

30.25

30.05

43.46

14809

143349

(3024731) MCV [Entitic mean volume] in Red Blood Cells

14882

144159

1.43

6.80

20.9

19.0

90.86

90.36

40.09

14808

143350

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

14882

144165

1.43

6.74

21.3

19.3

40.42

40.43

0.01

14805

143298

(3010813) Leukocytes [#/volume] in Blood

14884

144188

1.43

6.74

21.1

19.1

6.74

6.66

e9/l

3.68

14683

142047

(3023323) Follitropin [Units/volume] in Serum or Plasma

2073

18052

1.14

6.70

1.4

1.3

24.76

26.09

iu/l

1.10

1792

15738

(3026361) Erythrocytes [#/volume] in Blood

14882

144172

1.43

6.66

21.0

19.0

4.42

4.45

e12/l

17.99

14680

142074

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

637

5017

1.25

6.59

1.6

0.05

4.59

iu/ml

0.57

111

804

(3020779) Urea [Moles/volume] in Serum or Plasma

882

7189

1.21

6.56

9.1

6.9

7.80

7.45

mmol/l

0.97

847

6936

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6961

64675

1.09

6.50

2.6

2.5

76.28

1420.70

nmol/l

0.50

6523

60964

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8780

82419

1.09

6.48

3.4

74.40

71.26

ug/l

1.26

8369

78922

(3007461) Platelets [#/volume] in Blood

14875

144109

1.41

6.47

21.0

19.1

269.65

269.21

e9/l

0.38

14698

142261

(3005719) IgG [Mass/volume] in Serum or Plasma

1263

10643

1.17

6.43

3.0

2.7

10.44

10.42

g/l

0.06

1182

9883

(3000963) Hemoglobin [Mass/volume] in Blood

14882

144205

1.41

6.29

21.1

19.2

132.99

133.00

g/l

0.04

14809

143406

(3012544) pH of Venous blood

1012

8397

1.19

6.21

4.1

3.6

7.38

0.15

557

4520

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

610

4816

1.24

6.20

9.5

9.2

24.32

24.25

mmol/l

0.24

592

4737

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

684

5470

1.23

6.18

1.3

33.59

37.28

u/ml

0.20

329

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

349

1.90

5.90

3.2

2.7

0.60

0.61

mmol/l

0.99

349

(3048929) Epstein Barr virus Ab [Presence] in Serum

724

5853

1.22

5.89

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1361

11629

1.16

5.79

5.1

5.0

—

(3023368) Bacteria identified in Blood by Culture

2892

25926

1.11

5.62

4.1

3.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1186

10055

1.16

5.61

2.4

2.3

0.22

g/l

0.48

1117

9510

(3052851) Hemolysis interference index of Serum or Plasma

402

3059

1.29

5.60

3.2

2.5

1.55

2.02

index

1.02

222

1539

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

102

603

1.65

5.52

2.8

2.7

41.73

45.37

1.13

372

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

724

5900

1.21

5.45

7.8

7.1

24.75

24.70

mmol/l

0.14

719

5863

(3026389) Candida sp identified in Specimen by Organism specific culture

334

2489

1.32

5.45

1.4

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

625

7359

0.82

5.43

1.5

59.45

60.20

ug/l

0.16

625

7359

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12170

116303

1.10

5.40

16.3

14.7

13.37

0.12

12040

114966

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1310

11230

1.15

5.33

2.4

17.56

20.61

au/ml

1.20

178

1544

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4295

39337

1.09

5.27

2.9

2.8

23.33

47.17

ng/l

0.75

1925

18442

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11394

108593

1.09

5.22

3.9

3.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

105

2.60

5.21

8.0

10.8

4.86

4.98

mmol/l

0.09

105

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

318

2371

1.31

5.19

7.1

5.4

793.05

723.67

iu/ml

0.08

283

(3017732) Neutrophils [#/volume] in Blood

1994

17594

1.12

5.17

2.9

4.47

4.19

e9/l

0.76

1778

15770

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

629

5085

1.22

5.16

2.6

2.0

0.22

0.23

g/l

0.94

597

4865

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1151

9800

1.16

5.15

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

956

8025

1.17

5.15

7.8

7.0

1.20

1.24

mmol/l

0.71

937

7883

(3024354) Oxygen [Partial pressure] in Venous blood

830

6887

1.19

5.14

3.5

3.0

4.52

4.59

kpa

0.37

804

6692

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

998

8413

1.17

5.10

1.1

25.04

5.88

u/ml

0.54

104

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

335

2527

1.30

5.03

1.9

2.0

0.00

0.01

g/l

2.15

305

2299

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

373

2857

1.28

4.98

2.2

2.1

0.50

g/l

0.01

326

2526

(3016502) Oxygen saturation in Arterial blood

987

8329

1.17

4.98

7.8

7.7

96.08

96.26

0.36

947

8028

(3028026) IgM [Mass/volume] in Serum or Plasma

970

8180

1.17

4.94

1.8

1.38

1.32

g/l

0.28

904

7634

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12275

117487

1.10

4.89

4.9

36.82

37.25

mmol/mol

8.97

11720

112491

(3019977) pH of Arterial blood

1133

9678

1.15

4.87

7.6

7.3

7.42

0.31

582

5190

(3027801) Oxygen [Partial pressure] in Arterial blood

1130

9654

1.15

4.84

7.5

7.2

13.32

13.59

kpa

0.81

1079

9293

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

635

5175

1.21

4.82

9.5

0.66

0.68

0.72

630

5146

(3000093) Morphology [Interpretation] in Blood Narrative

128

827

1.51

4.81

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

856

7164

1.18

4.80

1.3

1.31

1.03

u/ml

0.22

545

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

654

5349

1.20

4.78

9.3

9.2

1.42

1.32

1.59

648

5318

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

640

5224

1.20

4.78

2.6

2.0

1.16

1.19

g/l

1.26

611

5013

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2149

19122

1.11

4.78

3.2

3.0

195.99

260.92

ng/l

1.00

1193

10601

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

261

1918

1.33

4.75

1.2

1.1

—

(3003396) Base excess in Arterial blood by calculation

1120

9578

1.15

4.74

7.4

7.2

0.83

0.79

mmol/l

0.12

901

7758

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1129

9661

1.15

4.74

7.5

7.2

5.07

5.04

kpa

0.71

1082

9310

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1219

10488

1.15

4.73

1.3

29.78

45.94

au/ml

3.21

602

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

622

5072

1.20

4.70

1.4

1.3

12.55

5.15

u/ml

1.15

482

(40768797) Stomach Pathology biopsy report

2033

18054

1.11

4.69

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

621

5066

1.20

4.68

1.4

10.32

8.99

u/ml

0.18

103

740

(36660697) Celiac disease serology panel - Serum

1592

13945

1.13

4.67

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

154

1041

1.45

4.64

2.3

2.5

22.89

23.89

mg/l

0.15

110

728

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

597

4858

1.21

4.62

1.4

24.90

25.55

u/l

0.19

467

3983

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

124

2.36

4.60

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

405

3167

1.25

4.59

2.2

2.0

2.85

2.80

g/l

0.49

373

2937

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

511

4098

1.22

4.59

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

140

934

1.47

4.52

3.2

2.8

13.62

14.46

index

0.43

543

(3014765) Yersinia sp identified in Stool by Organism specific culture

514

4132

1.22

4.51

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

515

4141

1.22

4.51

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

326

2491

1.28

4.49

2.5

2.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1029

8787

1.15

4.46

1.4

216.73

230.98

miu/ml

0.71

520

4512

(3019309) Folate [Moles/volume] in Red Blood Cells

1808

16014

1.11

4.37

1.7

1161.49

1182.64

nmol/l

0.46

1447

12657

(3004716) Salmonella sp identified in Stool by Organism specific culture

1083

9301

1.15

4.33

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

493

3965

1.22

4.33

1.3

0.61

22.82

u/ml

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4650

43008

1.08

4.32

3.1

2.9

0.39

0.11

estimate

0.55

1415

12874

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1077

9250

1.15

4.31

1.4

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

947

8064

1.15

4.28

8.2

8.0

119.01

120.15

g/l

1.09

925

7865

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

415

3285

1.24

4.25

2.2

2.0

3.52

3.59

g/l

0.51

383

3059

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

415

3286

1.24

4.24

2.2

2.0

4.23

4.30

g/l

1.05

383

3056

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2036

18177

1.11

4.24

3.5

3.1

0.82

0.83

mmol/l

2.87

1935

17212

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3537

32389

1.08

4.22

1.7

1.8

0.96

0.92

mg/l

0.37

2670

24649

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

415

3292

1.24

4.17

2.2

2.0

7.30

7.26

g/l

0.24

383

3060

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1002

8584

1.15

4.17

2.4

2.2

0.31

0.32

e6/l

0.03

932

8045

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1489

13090

1.12

4.12

6.7

5.0

1.04

mmol/l

0.18

1381

12170

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

246

1834

1.31

4.11

3.1

2.4

1786.90

9464.15

u/ml

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

311

2391

1.27

4.11

1.8

2.0

0.00

g/l

0.50

274

2116

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1227

10666

1.13

4.10

4.4

4.0

224.52

232.95

u/l

1.82

1172

10164

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

415

3300

1.23

4.09

1.3

1.2

38.52

43.97

u/ml

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

406

3223

1.23

4.07

3.7

2.9

1.41

1.31

mg/l

2.01

384

2992

(3023183) Ammonium ion [Moles/volume] in Plasma

230

1702

1.32

4.06

2.9

32.00

32.68

umol/l

0.19

216

1572

(3024928) Oxygen saturation in Venous blood

288

2200

1.28

4.02

3.8

3.2

61.36

62.39

0.34

275

2122

(3000570) Elastase.pancreatic [Mass/mass] in Stool

445

3575

1.22

3.98

1.3

1.4

328.11

303.22

ug/g

1.55

253

1847

(3020191) Ethanol [Moles/volume] in Serum or Plasma

136

927

1.43

3.98

1.5

1.33

1.16

promille

0.73

106

731

(3013826) Glucose [Moles/volume] in Serum or Plasma

7439

70100

1.07

3.96

4.6

4.2

6.24

6.30

mmol/l

1.72

6867

64273

(3008898) HLA-B27 [Presence]

919

7858

1.15

3.94

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

401

3191

1.23

3.94

1.6

380.59

383.72

mu/l

0.04

310

2581

(3034860) Kappa light chains.free [Mass/volume] in Serum

302

2329

1.27

3.91

3.2

3.1

35.15

62.17

mg/l

0.61

262

1981

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

292

2247

1.27

3.86

1.9

2.0

0.00

g/l

-0.00

273

2111

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

563

4641

1.19

3.85

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

214

1581

1.32

3.84

1.3

1.2

50.19

48.91

u/ml

0.02

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

301

2327

1.27

3.83

3.2

3.1

29.33

33.07

mg/l

0.61

262

1980

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2073

18619

1.10

3.82

2.6

2.3

2.42

2.47

g/l

4.13

1896

17253

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12579

120832

1.09

3.79

3.6

1.19

mmol/l

0.27

11975

115199

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

390

3110

1.23

3.77

1.3

1.2

282.79

252.32

u/ml

1.55

278

2050

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

382

3044

1.23

3.73

1.4

1.5

13.35

13.67

iu/ml

0.02

(3042733) HLA Ab [Presence] in Serum

316

1.73

3.73

4.3

5.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

365

2895

1.24

3.72

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

500

4093

1.20

3.71

1.4

1.3

2.41

3.58

u/ml

0.47

268

(3009445) Proteinase 3 Ab [Units/volume] in Serum

562

4654

1.18

3.66

1.6

6.14

10.30

iu/ml

0.74

116

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

478

3904

1.20

3.64

2.1

1.9

1.45

1.40

g/l

0.55

413

3401

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

182

1329

1.34

3.57

1.3

65.69

57.85

u/ml

0.15

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

580

4831

1.18

3.54

8.7

15.87

16.01

0.57

559

4638

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

356

2833

1.23

3.54

2.1

2.0

9.98

10.05

g/l

0.11

321

2584

(3024891) Influenza virus A+B Ag [Presence] in Specimen

528

4372

1.18

3.47

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2261

20481

1.09

3.45

2.6

2.3

14.71

14.32

umol/l

1.63

2111

19234

(21494890) Protein electrophoresis panel - 24 hour Urine

655

1.48

3.44

2.0

—

(3009508) Creatinine [Moles/volume] in Urine

3842

35537

1.07

3.43

3.5

3.3

7.25

7.34

mmol/l

0.54

3347

31103

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

577

1.51

3.41

2.4

210.08

140.33

au/ml

0.50

104

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1626

14514

1.10

3.41

2.1

381.29

376.81

nmol/l

0.42

1528

13528

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

231

1757

1.29

3.40

1.5

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

357

2859

1.22

3.36

2.2

2.0

390.78

445.77

ug/l

0.17

327

2587

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

968

8409

1.13

3.32

3.8

3.4

81.69

75.17

ng/l

1.40

867

7476

(3000330) Specific gravity of Urine by Test strip

651

5506

1.16

3.30

2.9

1.02

ratio

0.19

563

4809

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

905

9921

0.88

3.29

1.5

1.6

—

(3013762) Body weight Measured

4.88

3.29

1.0

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1703

15271

1.10

3.26

2.1

2.0

29.15

28.95

0.52

1659

14809

(3019230) Fractional oxyhemoglobin in Venous blood

247

1907

1.27

3.25

4.3

3.2

60.06

61.59

0.54

247

1902

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

263

2054

1.25

3.15

3.0

2.9

1.55

2.84

ratio

1.73

141

1140

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

296

2346

1.23

3.11

1.3

1.2

21.04

14.02

u/ml

0.35

106

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

365

1.61

3.08

2.0

1.8

763.75

5334.26

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

143

1033

1.35

3.07

7.3

6.5

12.31

11.48

mg/l

1.13

136

973

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

142

1.99

3.04

1.5

2.2

—

(3019225) pH of Specimen

1125

9924

1.11

2.99

3.3

3.6

7.36

7.35

0.26

777

7012

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2543

23285

1.08

2.97

2.7

2.6

774.69

690.29

ng/l

0.38

2102

19143

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

164

1217

1.32

2.95

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

524

4408

1.16

2.90

2.5

2.4

3.67

3.60

g/l

0.45

492

4189

(3038026) Centromere Ab [Units/volume] in Serum

156

1154

1.32

2.88

1.3

30.65

57.97

u/ml

1.01

(3004119) Hemoglobin [Mass/volume] in Venous blood

605

5150

1.15

2.86

3.4

3.0

128.91

129.78

g/l

0.48

592

5004

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

161

1198

1.31

2.86

1.7

2.0

20.67

24.26

mg/l

0.44

448

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

517

4350

1.16

2.86

1.3

42.59

42.68

u/ml

0.00

428

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

162

1207

1.31

2.85

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

470

3926

1.17

2.85

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

412

1.54

2.83

2.4

3.3

2514.36

2765.11

mg/l

0.03

301

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

135

984

1.34

2.77

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

385

1.55

2.72

1.9

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

140

1030

1.33

2.71

1.3

1.4

—

(3049233) Organic acids panel - Urine

8.13

2.70

1.2

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

489

4120

1.16

2.68

1.3

—

(3025159) Blasts/Leukocytes in Blood

1205

10736

1.10

2.67

4.8

4.6

0.15

0.30

0.62

276

2240

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

201

1558

1.26

2.63

1.4

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

384

3178

1.18

2.63

1.4

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

809

7067

1.12

2.60

2.3

66.79

67.10

g/l

0.57

737

6576

(3002179) Metamyelocytes/Leukocytes in Blood

1168

10407

1.10

2.59

4.4

4.2

0.64

0.70

0.19

308

2587

(3014148) Varicella zoster virus Ab [Titer] in Serum

349

2869

1.19

2.59

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

647

1.40

2.57

3.2

3.1

9.44

8.63

mg/l

0.36

520

(3001964) Herpes simplex virus Ag [Presence] in Specimen

383

1.53

2.56

1.3

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

416

1.50

2.52

30.2

27.1

109.49

115.62

ug/l

0.37

336

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5688

53671

1.05

2.50

1.8

1.33

1.31

mmol/l

0.63

4975

47060

(3017181) Myelocytes/Leukocytes in Blood

1218

10897

1.10

2.49

4.6

4.4

0.76

0.92

0.95

317

2691

(3003181) Sodium [Moles/volume] in Urine

193

1500

1.26

2.49

1.5

1.4

56.73

64.96

mmol/l

2.03

160

1178

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13309

128549

1.08

2.45

4.3

4.81

4.83

mmol/l

1.78

12809

123526

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1820

16580

1.08

2.44

2.8

2.4

23.82

23.46

0.56

1678

15448

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

330

2716

1.19

2.44

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

1176

10517

1.10

2.43

4.6

4.4

0.08

0.13

1.51

276

2315

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

216

1706

1.24

2.43

1.5

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1390

12528

1.09

2.42

3.5

3.6

4.59

4.55

pmol/l

0.60

1251

11433

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

381

1.51

2.41

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

381

1.51

2.41

1.2

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

433

3648

1.16

2.41

2.5

2.2

10.49

10.74

mg/l

0.34

414

3451

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1052

9369

1.10

2.38

2.5

2.4

74.63

76.60

ml/min/173m2

0.87

438

3845

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

488

1.44

2.33

1.6

145.06

123.97

au/ml

0.22

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

440

1.46

2.33

9.4

4.9

65.47

1780.44

u/ml

0.57

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

140

1057

1.29

2.31

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13392

129433

1.08

2.28

4.7

2.85

2.87

mmol/l

1.76

12820

123936

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

250

2020

1.21

2.28

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

671

5849

1.12

2.27

2.0

2.1

5.75

5.67

ug/l

0.02

594

5093

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.12

2.26

1.0

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

203

1610

1.23

2.23

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

381

3202

1.16

2.22

3.3

3.5

199.79

355.35

u/ml

0.80

321

2737

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

140

1064

1.29

2.21

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

672

5870

1.12

2.21

2.3

2.1

39.94

39.96

u/l

0.01

632

5460

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

132

997

1.29

2.19

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

936

0.71

2.18

1.3

1.5

0.50

e9/l

0.03

936

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

354

2964

1.17

2.17

1.4

1.3

151.80

154.38

au/ml

0.16

781

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

528

4550

1.14

2.17

2.2

2.3

169.21

171.96

0.35

502

4297

(3007463) Buprenorphine [Presence] in Urine

2.07

2.14

12.2

7.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.02

2.12

1.0

1.6

—

(3013512) EKG study

3641

34078

1.06

2.12

2.8

0.78

0.73

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

641

1.36

2.07

1.9

2.3

143.90

155.00

umol/l

0.14

299

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

374

3159

1.16

2.07

1.4

1.3

26.24

19.60

u/ml

—

(3033099) Centromere Ab [Titer] in Serum

428

1.44

2.05

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3268

30528

1.06

2.04

2.4

2.1

297.02

299.04

umol/l

0.66

2972

27753

(3004616) Nuclear Ab [Presence] in Serum

253

2074

1.19

2.02

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

669

1.34

2.02

2.1

1.9

8.94

9.31

mg/l

0.27

554

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

281

2325

1.18

2.02

2.5

2.6

19.62

25.85

iu/ml

0.48

143

(3017354) Segmented neutrophils/Leukocytes in Blood

128

975

1.28

2.02

3.2

2.9

56.62

55.84

0.20

112

854

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

342

1.48

2.00

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

155

1210

1.25

2.00

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

189

1508

1.22

2.00

2.9

1.34

1.43

0.16

172

1381

(3027945) Reticulocytes/Erythrocytes in Blood

1102

9934

1.09

1.96

2.6

2.5

1.78

1.75

0.38

988

8921

(3037121) Protein [Mass/volume] in Urine

411

3512

1.15

1.95

3.1

2.9

410.56

417.78

mg/l

0.02

167

1429

(3044242) Glucose [Moles/volume] in Arterial blood

377

1.45

1.93

2.2

2.0

8.11

7.95

mmol/l

0.11

377

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

134

1035

1.26

1.91

1.1

1.2

24.29

186.96

titre

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

110

1.86

1.91

1.0

1.1

1.62

1.46

umol/24h

0.42

110

(40768443) Skin Pathology biopsy report

658

5797

1.11

1.90

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1441

13149

1.08

1.90

3.8

4.0

32.69

32.71

0.03

1070

9716

(3027456) Digoxin [Moles/volume] in Serum or Plasma

112

848

1.29

1.88

3.1

3.4

0.75

0.80

nmol/l

0.82

658

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1737

15963

1.07

1.87

1.2

1.3

156.45

146.58

u/ml

0.40

660

6439

(3005322) IgE [Units/volume] in Serum or Plasma

1343

12231

1.08

1.87

1.3

217.60

177.56

u/ml

0.58

1256

11454

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

134

1042

1.26

1.82

1.1

1.2

336.36

176.50

titre

0.89

180

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13241

128082

1.06

1.81

4.2

1.55

mmol/l

0.11

12688

122713

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

479

4158

1.13

1.81

2.1

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

1063

1.25

1.78

1.2

85.99

80.64

0.91

(3016038) Potassium [Moles/volume] in Urine

558

1.35

1.77

1.4

1.3

32.12

32.76

mmol/l

0.08

491

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

251

2086

1.18

1.76

3.3

3.6

0.38

0.37

iu/ml

0.23

118

1130

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

106

807

1.28

1.73

1.7

1.6

3297571.43

1405564.05

iu/ml

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

544

1.35

1.72

1.1

2.32

1.92

u/ml

0.11

308

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

234

1946

1.18

1.65

1.1

1.2

478.16

289.68

titre

0.48

158

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

625

5542

1.10

1.64

3.3

2.9

5.12

5.10

kpa

0.18

595

5320

(3006922) Hepatitis E virus Ab [Presence] in Serum

144

1145

1.23

1.64

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.44

1.64

2.9

3.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

558

1.33

1.63

1.2

1.3

17.91

17.82

pmol/l

0.02

511

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

178

1448

1.20

1.62

1.5

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

325

2777

1.14

1.61

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

613

5437

1.10

1.61

1.4

78.75

101.50

pmol/l

1.46

605

5300

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

697

1.29

1.58

4.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

281

0.55

1.58

1.0

1.24

1.23

mom

0.04

281

(3009466) Valproate [Moles/volume] in Serum or Plasma

200

1649

1.19

1.57

5.0

5.8

369.72

378.06

umol/l

0.35

177

1446

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

163

1.62

1.56

1.6

1.7

—

(3049717) Cytology report of Urine Cyto stain

247

2074

1.16

1.56

1.9

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

300

2556

1.15

1.56

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.27

1.55

1.3

1.2

—

(40768441) Liver Pathology biopsy report

123

969

1.24

1.54

1.6

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.44

1.54

2.4

1.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.44

1.54

1.0

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

632

1.30

1.53

1.5

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

771

1.27

1.51

2.4

2.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

167

1361

1.20

1.51

3.0

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

186

1531

1.19

1.51

1.5

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

243

1.49

1.50

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

186

1533

1.19

1.49

1.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

644

1.29

1.48

1.5

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

741

6663

1.09

1.47

1.6

15.09

11.84

u/ml

0.48

196

1785

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

517

1.32

1.47

1.3

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

492

1.33

1.46

2.7

2.2

31.01

29.42

0.37

492

(3025468) Yersinia sp identified in Specimen by Organism specific culture

185

1527

1.18

1.46

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

215

1797

1.17

1.46

1.1

1.47

g/l

0.00

201

1651

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

663

1.28

1.46

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1065

9719

1.07

1.46

3.6

3.9

12.73

20.81

ug/l

0.55

809

7147

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

431

3776

1.12

1.46

2.0

1.9

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

263

1.45

1.41

2.0

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

130

1.65

1.40

1.3

1.1

93.09

87.88

titre

0.12

130

(3016650) Hepatitis A virus Ab [Presence] in Serum

290

2487

1.14

1.40

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.66

1.39

1.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

240

1.46

1.38

1.1

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

138

1116

1.21

1.38

13.3

13.5

0.63

0.62

mmol/l

0.45

133

1026

(3015235) Bicarbonate [Moles/volume] in Capillary blood

341

2962

1.13

1.36

2.7

2.5

24.60

24.63

mmol/l

0.07

335

2911

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

537

4780

1.10

1.36

2.0

95.66

96.81

0.57

510

4573

(3021387) Prolactin [Units/volume] in Serum or Plasma

1101

10091

1.07

1.35

1.5

1.6

288.15

315.48

mu/l

1.68

997

8986

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

157

1289

1.19

1.34

1.1

1.2

1.01

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1234

11355

1.06

1.34

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

569

1.29

1.33

1.2

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

448

3959

1.11

1.32

3.5

49.36

48.24

0.44

442

3898

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.12

1.32

6.6

3.9

—

(3028433) Virus identified in Specimen by Culture

358

1.36

1.31

1.2

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

122

981

1.21

1.31

2.0

1.8

128.82

125.64

0.22

117

924

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

126

1.63

1.28

1.6

2.1

0.76

0.91

u/field

0.26

126

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

635

5718

1.09

1.26

2.4

2.5

143.08

114.35

ng/l

1.00

566

5167

(3009343) pH of Capillary blood

598

5373

1.09

1.25

3.3

2.9

7.42

0.02

487

4434

(3050794) Legionella sp Ab [Presence] in Serum

1.82

1.25

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

345

1.36

1.24

2.5

2.2

16.31

15.87

0.52

345

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1480

1.17

1.24

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

421

1.32

1.24

1.1

1.2

—

(3024471) HLA-A [Type]

312

1.38

1.24

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

405

3575

1.11

1.24

1.2

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

173

1446

1.17

1.23

1.2

—

(3016228) CD19 cells/cells in Blood

473

1.30

1.22

2.7

2.1

8.54

7.61

0.33

464

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

708

1.24

1.21

1.2

—

(3022689) Creatine [Moles/volume] in Urine

347

1.35

1.21

1.5

1.4

7.43

7.89

mmol/l

0.30

347

(3050129) First trimester maternal screen panel - Serum or Plasma

1311

13464

0.94

1.21

1.5

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

1.84

1.19

1.2

1.3

8.81

1.22

ml/s/173m2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

304

0.64

1.19

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.11

1.18

1.0

1.1

194.97

232.29

nmol/l

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

737

1.23

1.18

1.1

—

(3010503) CD19 cells [#/volume] in Blood

737

1.23

1.18

3.4

2.7

203.14

187.10

e6/l

0.08

723

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

485

1.29

1.17

1.3

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

184

1553

1.16

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

123

1004

1.20

1.16

2.3

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

253

2184

1.13

1.16

1.4

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

250

1.41

1.16

1.1

26.00

34.38

titre

—

(4024509) Urine culture

623

5634

1.08

1.14

1.7

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

239

2058

1.13

1.14

3.0

2.5

8.82

8.71

kpa

0.28

232

2021

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1766

1.14

1.2

—

(3003694) ABO and Rh group [Type] in Blood

4945

47164

1.03

1.13

1.7

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1494

1.16

1.13

1.2

—

(3044941) Cell count panel - Synovial fluid

206

1758

1.14

1.13

1.4

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

269

2336

1.13

2.2

2.0

128.95

130.64

g/l

0.60

195

1832

(3023520) Reticulocytes [#/volume] in Blood

781

7129

1.07

1.12

2.7

2.5

72.10

71.55

e9/l

0.13

571

5023

(3038177) Helicobacter pylori Ab [Presence] in Serum

353

3114

1.11

1.12

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.12

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

444

3965

1.09

1.10

1.1

—

(4211845) Urine protein measurement

683

1.23

1.09

2.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

1545

1.15

1.08

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.20

1.08

2.4

3.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

383

3402

1.10

1.07

1.4

10815.62

1346.51

e6/l

0.46

292

2668

(3020961) Endomysium IgA Ab [Titer] in Serum

997

9191

1.06

1.07

1.1

176.44

180.45

titre

0.02

242

(1761868) Lipid panel - Serum or Plasma

6198

61509

0.97

1.07

2.5

2.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

288

1.36

1.06

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

650

1.23

1.06

1.8

2.1

52.00

21.22

ug/l

1.08

641

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

149

1.51

1.06

1.6

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

190

1623

1.14

1.05

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

107

873

1.20

1.04

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1542

1.15

1.04

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

442

3960

1.09

1.04

1.1

—

(4015189) Microbial culture of sputum

166

1.47

1.03

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

519

4684

1.08

1.03

1.2

4.70

4.24

0.60

847

(3047189) Immunofixation for 24 hour Urine

282

1.35

1.02

2.1

1.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

376

3351

1.10

1.00

1.3

67.60

28.64

e6/l

0.54

275

2479

(3006462) Nitrate [Presence] in Urine

620

1.23

1.00

2.5

2.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

510

4611

1.08

0.98

3.2

2.7

1.49

mmol/l

0.01

360

3273

(3020891) Body temperature

430

3861

1.09

0.98

4.4

4.2

36.92

°c

0.01

425

3824

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

259

1.36

0.98

1.1

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.75

0.97

1.2

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

849

0.81

0.96

13.5

14.4

837.01

2352.35

nmol/l

0.50

824

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

425

3818

1.09

0.96

1.3

503.18

458.40

mg/l

0.46

410

3670

(3052592) Norovirus Ag [Presence] in Stool

161

1.45

0.95

1.2

—

(3011412) CD3 cells [#/volume] in Blood

154

1307

1.15

0.95

2.8

2.4

1431.69

1324.71

e6/l

0.37

137

1113

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

153

1.47

0.95

6.5

4.9

38.87

32.51

ug/min

0.30

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

189

1627

1.13

0.95

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

561

5098

1.08

0.95

6.0

6.3

24.41

24.37

mmol/l

0.09

536

4859

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

901

0.82

0.95

16.0

19.4

1368.04

3356.48

nmol/l

0.86

861

(3023410) Appearance of Cerebral spinal fluid

185

1591

1.14

0.95

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2014

20328

0.96

0.94

1.5

1.6

1050.87

1014.06

mu/l

0.74

1629

16953

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1593

1.13

0.93

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

148

1255

1.15

0.93

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1091

10133

1.05

0.93

2.8

2.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

186

1603

1.13

0.93

1.1

1.2

34.40

37.30

mg/l

0.60

152

1363

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.17

0.92

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

280

2473

1.11

0.92

1.8

1.7

7107.99

8707.60

e6/l

0.84

204

1772

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1672

16930

0.96

0.92

1.5

1.6

3.47

3.45

mmol/l

0.19

1092

11017

(3033923) Metanephrine [Moles/time] in 24 hour Urine

229

1.36

0.91

1.0

1.1

0.57

0.62

umol/24h

0.30

109

(3000034) Microalbumin [Mass/volume] in Urine

789

1.19

0.90

2.9

2.6

138.63

50.08

mg/l

0.64

541

(3039162) Centromere protein B Ab [Units/volume] in Serum

261

2300

1.11

0.90

1.4

1.3

46.43

54.19

u/ml

0.17

137

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

272

2405

1.10

0.88

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

148

0.59

0.88

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

0.55

0.88

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

152

0.58

0.88

2.7

2.8

1060.33

2292.94

u/l

—

142

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

152

0.58

0.88

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

191

1657

1.13

0.87

1.5

1.4

—

(40761536) Microorganisms panel - Urine sediment

1264

11808

1.05

0.87

3.8

3.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

368

1.27

0.86

1.8

1.7

8.51

8.76

ug/l

0.17

368

(3007566) Smooth muscle Ab [Titer] in Serum

449

4065

1.08

0.86

1.3

95.35

135.07

titre

0.63

408

(3025018) Bordetella pertussis Ab [Titer] in Serum

168

1447

1.13

0.86

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

116

974

1.16

0.85

1.2

9.90

9.46

mm/h

0.18

116

974

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

114

957

1.16

0.85

2.0

1.7

100.45

102.99

0.30

106

856

(3020876) Protein [Mass/time] in 24 hour Urine

118

994

1.16

0.84

2.5

1.38

1.18

g/24h

0.38

564

(3036489) Thrombin time

602

5516

1.07

0.84

1.9

20.40

20.27

0.24

520

4658

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

353

1.27

0.83

2.2

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

127

1077

1.15

0.83

1.9

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

270

2888

0.91

0.82

1.6

7.56

7.59

mmol/l

0.10

263

2775

(3024932) HLA-DR beta [Type]

302

1.29

0.82

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.74

0.81

1.8

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

110

925

1.16

0.81

3.3

3.0

—

(44806420) Estimation of glomerular filtration rate

220

2374

0.90

0.80

2.1

2.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

727

1.18

0.80

1.2

29.80

20.37

u/l

0.41

611

(3028192) IgG subclass 2 [Mass/volume] in Serum

178

1548

1.12

0.80

1.4

2.85

3.00

g/l

0.62

134

1130

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

207

1816

1.11

0.80

1.1

1.18

1.05

—

115

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

180

1567

1.12

0.80

1.0

1.1

196.68

212.24

mg/l

1.27

158

1396

(3024139) IgG subclass 3 [Mass/volume] in Serum

178

1549

1.12

0.80

1.4

0.38

g/l

0.02

135

1135

(3021901) Oxygen saturation in Capillary blood

199

1744

1.11

0.79

3.1

2.6

92.14

91.97

0.22

193

1711

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.79

0.0

1.0

—

0.12

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.07

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

114

964

1.15

0.79

2.0

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

711

1.18

0.78

1.2

120.79

117.04

0.38

634

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

729

1.18

0.78

1.6

7.08

6.56

u/l

0.09

590

(21494755) Public health laboratory ask at order entry panel

1909

19203

0.96

0.77

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

152

1313

1.13

0.77

1.2

64.87

58.01

u/l

0.39

136

1165

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

330

0.74

0.77

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

270

2407

1.10

0.77

1.5

0.62

0.59

g/l

0.22

212

1885

(40765096) Chromosome analysis panel by Banding

228

1.33

0.77

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.77

0.76

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

130

1113

1.14

0.76

1.5

1.6

280.38

280.10

mosm/kgh2o

0.05

100

856

(4062490) Immunoglobulin typing, IgG

175

1527

1.12

0.76

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

741

1.17

0.75

1.2

80.18

84.87

u/l

0.21

639

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

687

1.18

0.75

1.1

100.37

99.49

0.08

291

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

135

1161

1.14

0.74

1.2

1.3

2.14

1.91

mmol/l

0.80

129

1085

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1032

0.86

0.74

6.9

7.1

14.56

42.08

ug/l

0.91

675

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

260

0.71

0.74

1.2

11.10

9.69

pmol/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

104

879

1.15

0.74

1.4

1.5

20358.67

58329.81

e6/l

1.22

575

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

375

3400

1.08

0.73

1.2

3.53

3.59

mmol/l

0.64

363

3209

(4034850) Laboratory test

416

3787

1.07

0.73

8.2

7.6

—

(40760409) HLA-A [Type] by High resolution

1.63

0.73

1.0

—

(40760410) HLA-B [Type] by High resolution

1.63

0.73

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

520

1.20

0.72

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

144

1247

1.13

0.72

1.4

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

177

1552

1.11

0.72

1.4

7.03

6.53

g/l

0.92

133

1134

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

122

1.44

0.72

1.8

2.1

—

(40763590) HLA-DQ beta [Type]

1.60

0.71

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.60

0.71

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

134

1156

1.13

0.71

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

723

0.84

0.71

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

306

2757

1.08

0.71

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

165

1443

1.12

0.70

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

165

1443

1.12

0.70

1.5

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

139

1.40

0.70

1.1

0.11

15.79

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

478

1.20

0.69

1.0

1.1

33.30

26.92

iu/ml

0.40

478

(44790048) Parainfluenza type 2 nucleic acid detection

165

1445

1.11

0.69

1.5

1.4

—

(3013862) HLA-DP [Type]

1.54

0.69

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

165

1.36

0.68

1.1

1.5

91.55

53.16

ng/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

285

1.27

0.68

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.67

0.68

1.0

288.00

253.90

u/ml

—

(3036180) Methadone [Presence] in Urine

1.67

0.68

6.6

1.9

—

(44790047) Parainfluenza type 1 nucleic acid detection

165

1447

1.11

0.68

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

596

1.18

0.68

1.3

1.4

13.68

13.48

pmol/l

0.16

499

(3020682) Albumin/Creatinine [Ratio] in Urine

3146

30037

1.03

0.68

4.2

4.0

9.61

8.56

mg/mmol

0.44

1849

17827

(3020491) Glucose [Moles/volume] in Blood

118

1015

1.13

0.67

1.5

1.6

5.81

5.99

mmol/l

0.34

798

(3000919) Neutrophils/Leukocytes in Pleural fluid

118

0.58

0.67

1.3

1.4

18.71

23.86

—

105

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.55

0.67

4.8

5.8

11.04

10.88

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

101

860

1.15

0.67

1.7

1.83

9.12

nmol/l

0.61

697

(3029612) Listeria sp Ab [Titer] in Serum

1.63

0.66

1.7

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

348

1.23

0.66

2.4

2.0

2.01

1.86

ratio

0.25

338

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

12063

116999

1.03

0.65

17.2

15.4

331.95

331.63

g/l

4.34

12008

116358

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

550

5663

0.95

0.65

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

272

2869

0.92

0.65

1.4

1.5

—

(3019174) dRVVT (LA screen)

175

1.34

0.65

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1243

12553

0.96

0.65

1.7

—

(3012516) Albumin [Mass/volume] in Urine

3105

29659

1.03

0.65

3.6

3.4

50.13

46.67

mg/l

0.33

1854

17682

(3020717) Zinc [Moles/volume] in Serum or Plasma

123

1064

1.13

0.65

1.4

1.5

22.44

24.19

umol/l

0.30

114

990

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

411

1.21

0.64

3.4

3.0

121.47

83.50

ng/l

0.35

197

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

605

5603

1.06

0.64

2.2

23.75

19.49

iu/l

0.07

273

2522

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

626

5803

1.05

0.64

1.3

—

103.20

—

(3023419) Bacteria identified in Sputum by Culture

126

1093

1.13

0.64

3.3

2.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

564

1.18

0.63

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

700

7149

0.95

0.62

1.1

0.53

0.58

ratio

1.39

732

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

674

1.16

0.62

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

246

1.27

0.61

1.7

1.4

0.22

0.35

mmol/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

152

1.35

0.61

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

154

1357

1.11

0.60

1.2

118.27

117.63

pmol/l

0.05

154

1357

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

285

2584

1.08

0.60

1.1

3.06

2.90

0.13

552

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

344

1.22

0.59

1.1

1.2

10.61

12.08

u/l

0.44

316

(3027273) Bicarbonate [Moles/volume] in Venous blood

384

3520

1.07

0.59

3.0

25.57

25.33

mmol/l

0.89

367

3391

(3017509) Phencyclidine [Presence] in Urine

230

1.27

0.59

1.6

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.59

0.0

1.0

—

4.88

—

(3039000) Anion gap in Blood by calculation

201

1798

1.09

0.59

5.8

6.0

11.22

11.17

mmol/l

0.09

183

1620

(3001556) Androgen free Index in Serum or Plasma

248

0.75

0.58

1.1

1.0

—

(3018572) Chloride [Moles/volume] in Blood

201

1799

1.09

0.58

5.8

6.0

105.60

105.55

mmol/l

0.04

183

1621

(3047007) Chlamydophila sp Ab [Presence] in Serum

308

2805

1.07

0.58

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2203

21987

0.97

0.58

2.0

—

6.30

—

(3003129) Base excess in Capillary blood by calculation

114

991

1.12

0.58

1.7

2.0

0.78

0.77

mmol/l

0.01

108

928

(40761539) Cells [Type] in Urine sediment by Light microscopy

236

0.74

0.57

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

345

0.79

0.57

1.0

0.01

0.12

u/ml

0.70

205

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

134

1177

1.11

0.57

3.1

46.61

3.69

nmol/l

0.52

129

1122

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

137

1.35

0.57

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

180

1.30

0.56

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

206

1.28

0.56

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

312

2848

1.07

0.56

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

766

0.87

0.56

1.3

1.5

123.19

131.11

nmol/l

1.07

766

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

200

1795

1.09

0.55

1.6

1.4

582.05

444.00

pmol/l

0.42

175

1583

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

135

1189

1.11

0.55

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

158

1403

1.10

0.55

2.2

2.1

117.82

1006.75

u/ml

0.71

158

1393

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

134

1181

1.11

0.54

1.0

—

(4281824) Cell count and differential, peritoneal fluid

203

1826

1.09

0.54

1.1

—

(44813793) Dust mix specific IgE antibody measurement

151

1340

1.10

0.54

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

638

1.15

0.54

1.3

1.2

6.14

6.17

mmol/l

0.03

597

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

803

1.13

0.54

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

742

0.87

0.53

1.8

2.0

3.95

3.93

mmol/l

0.21

736

(3035285) Chloride [Moles/volume] in Venous blood

742

0.87

0.53

1.8

2.0

105.53

105.78

mmol/l

0.23

736

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

323

1.21

0.52

2.0

2.86

73.28

ug/min

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

132

1419

0.91

0.52

1.2

1.3

0.68

1.45

u/ml

1.60

788

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

170

1521

1.09

0.52

1.0

1.1

8.61

7.85

iu/ml

0.17

468

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.42

0.52

3.2

3.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

200

1.27

0.52

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

132

0.66

0.51

13.0

10.6

6.82

6.08

kpa

—

132

(3043410) Blood group antigens tested for on Red Blood Cells

324

1.20

0.51

1.9

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

242

0.77

0.51

1.0

0.04

u/ml

—

109

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.44

0.51

1.9

1.5

305.15

569.30

nmol/l

2.12

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.44

0.51

1.0

1.1

0.03

0.05

u/ml

0.78

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

509

0.84

0.51

1.0

28.68

40.50

ng/l

2.89

380

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.39

0.50

3.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

180

1618

1.09

0.50

1.8

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

670

1.14

0.50

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

524

1.15

0.50

1.7

2.0

0.23

0.18

e9/l

0.25

231

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

689

1.13

0.49

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.55

0.48

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

207

0.75

0.48

1.3

1.1

2.11

1.89

iu/ml

—

106

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

104

0.66

0.48

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

724

0.87

0.48

1.8

2.0

1.20

mmol/l

0.05

718

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

250

0.78

0.48

1.4

1.3

1.18

1.19

mmol/l

0.14

250

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

408

1.17

0.48

1.1

93.22

89.25

—

(3002619) Bacteria identified in Specimen by Culture

336

1.19

0.48

1.4

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

701

1.13

0.47

1.1

104.16

96.09

1.94

294

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

286

2624

1.06

0.47

1.6

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

283

1.21

0.47

5.8

4.0

4.95

4.84

kpa

0.20

283

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

283

1.21

0.47

5.8

4.0

11.12

10.66

kpa

0.27

283

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

409

1.17

0.47

1.6

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

238

0.78

0.46

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

218

2277

0.93

0.46

3.4

3.2

24.12

23.10

mg/l

0.14

125

1519

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

592

1.14

0.46

1.5

1.6

2.09

u/field

0.00

426

(3005033) Fetal Nuchal fold Thickness US

892

8985

0.97

0.46

1.5

1.26

0.09

629

6516

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

410

1.17

0.46

1.6

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

410

1.17

0.46

2.5

2.2

14.54

14.86

umol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.42

0.45

2.7

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

309

2846

1.06

0.45

3.4

2.9

24.68

24.74

mmol/l

0.15

290

2644

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

502

0.85

0.45

1.0

250.61

394.61

ng/l

1.34

383

(3045716) Anion gap in Serum or Plasma by calculation

107

945

1.10

0.45

3.6

3.0

10.64

10.67

mmol/l

0.03

107

925

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

172

1553

1.08

0.45

1.4

1.3

5.49

5.43

umol/l

0.09

155

1398

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

407

0.84

0.45

1.2

1.3

143.15

112.36

nmol/l

0.46

314

(1617658) Protocol used for examination of sentinel lymph nodes

151

1356

1.09

0.45

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

321

1.19

0.44

1.2

0.53

0.36

nmol/l

0.55

214

(3020650) Glucose [Presence] in Urine

576

1.13

0.44

1.6

0.00

0.04

estimate

2.37

576

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

328

3030

1.06

0.44

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.37

0.43

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

3.72

1.93

mg/l

—

123

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

3.48

1.84

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

0.21

2.57

mg/l

—

114

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

2.81

4.68

mg/l

—

103

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

0.90

0.78

mg/l

—

112

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

0.16

1.15

mg/l

—

100

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

1.30

1.74

mg/l

—

115

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

6.81

1.85

mg/l

—

114

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

170

0.75

0.43

2.0

1.5

0.84

2.35

mg/l

—

109

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

799

1.11

0.43

1.1

6.98

11.50

u/ml

0.68

136

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.63

0.43

3.2

2.1

1.95

2.24

mu/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

551

0.87

0.43

2.1

2.2

1.49

1.28

ug/l

0.26

528

(4212803) Bone marrow aspirate examination

1.44

0.42

1.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

141

1267

1.09

0.42

1.3

1.2

0.62

0.65

ratio

0.24

744

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

141

1267

1.09

0.42

1.4

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.64

0.42

1.0

5.99

0.30

u/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

205

2135

0.94

0.42

4.2

2.8

0.88

0.89

nmol/l

0.02

181

1842

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.52

0.41

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

451

1.15

0.41

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

128

1.30

0.41

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.41

0.0

1.2

—

(4268621) Lupus anticoagulant assay

227

2081

1.06

0.41

2.2

2.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

157

0.75

0.40

2.8

2.1

5.37

6.70

mmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

211

0.79

0.40

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

506

0.87

0.40

1.0

861.76

783.98

ng/l

0.46

373

(3034274) Bile acid [Moles/volume] in Serum --fasting

499

4675

1.04

0.40

2.0

2.2

4.50

5.40

umol/l

2.04

359

3390

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

262

2701

0.94

0.39

1.2

1.1

117.77

119.89

0.56

238

2461

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

164

1.25

0.39

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

103

1.33

0.39

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

342

3177

1.05

0.39

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

200

1.22

0.39

2.7

1.9

566673.26

288029.61

nmol/l

0.30

167

(3011985) Renin [Units/volume] in Plasma

213

1954

1.06

0.38

2.1

1.8

65.26

52.15

mu/l

0.42

198

1777

(3042111) Morphology [Interpretation] in Bone marrow Narrative

132

1190

1.08

0.38

1.7

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.35

0.38

2.1

231.36

251.82

ug/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

474

1.13

0.37

1.2

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.35

0.37

1.2

1.0

17.00

9.77

u/l

0.39

(3011048) Pyruvate [Moles/volume] in Blood

110

0.71

0.37

1.9

1.5

94.50

75.42

umol/l

—

101

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.29

0.36

1.0

1.4

233.11

165.43

ug/g

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

840

0.90

0.36

1.0

1.1

90.43

92.37

0.22

675

(3047352) Trisomy 18 risk [Likelihood] in Fetus

908

9096

0.97

0.36

1.5

—

(3034426) Prothrombin time (PT)

494

1.13

0.36

1.2

27.79

27.66

0.07

494

(3003157) Bacteria [#/volume] in Mother's milk

0.65

0.35

7.0

7.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

109

979

1.09

0.35

2.9

2.4

556.34

502.87

e6/l

0.74

766

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

153

0.76

0.35

1.1

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

714

7173

0.97

0.35

1.8

1.7

3.50

4.09

mg/l

1.17

516

5265

(3032352) Blasts [#/volume] in Cerebral spinal fluid

114

1.28

0.35

2.7

1.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

755

1.10

0.35

1.2

0.29

0.30

g/l

0.54

598

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.33

0.35

1.2

0.32

1.78

mmol/l

—

(3037756) Immunofixation for Serum or Plasma

153

1394

1.07

0.35

2.2

1.7

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.39

0.35

1.5

1.4

277.50

147.91

nmol/l

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

174

0.78

0.34

2.0

1.6

1.20

1.92

mg/l

—

113

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

163

0.78

0.34

1.3

1.1

0.38

0.63

iu/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

248

0.83

0.34

1.0

1.3

0.75

116.23

mg/l

2.57

178

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

141

0.76

0.34

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

276

1.17

0.34

3.2

2.6

—

(3024869) Neuronal Ab [Presence] in Serum

150

1.24

0.34

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

930

9297

0.97

0.33

1.5

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

414

1.13

0.33

1.1

70.14

74.56

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

148

1351

1.07

0.33

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

320

0.85

0.32

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

516

0.89

0.32

1.7

1.5

3.50

4.70

0.46

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

573

1.11

0.32

1.4

1.3

—

(4195642) Thrombophilia screening test

263

2688

0.95

0.32

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

160

1658

0.94

0.31

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

214

0.82

0.31

2.4

2.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

546

1.11

0.31

1.0

1.1

33.25

295.24

ng/l

0.92

131

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

820

0.92

0.31

1.2

1.1

—

(3010421) pH of Blood

338

3166

1.04

0.30

3.5

2.7

7.41

0.13

333

3129

(3047181) Lactate [Moles/volume] in Blood

309

2889

1.04

0.30

4.7

1.15

1.21

mmol/l

0.87

277

2564

(3034770) Mitochondria Ab [Titer] in Serum

427

4019

1.04

0.30

1.3

1117.22

860.14

titre

0.36

145

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

123

1120

1.07

0.30

1.1

307.00

300.72

mg/l

0.47

114

1016

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.31

0.29

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

191

0.82

0.29

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

777

0.92

0.29

1.0

15.30

9.32

u/ml

1.24

528

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

181

1672

1.06

0.29

1.2

1.3

0.16

0.20

nmol/l

1.00

135

1178

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

317

1.14

0.29

1.3

1.6

0.39

0.42

ug/l

0.17

241

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

201

0.82

0.29

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

222

0.83

0.29

1.0

0.69

0.35

u/ml

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

113

1029

1.07

0.28

3.2

2.5

228.98

224.73

e6/l

0.09

847

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

400

3769

1.04

0.28

4.5

4.4

1.77

1.66

1.05

378

3562

(3018001) Oat IgE Ab [Units/volume] in Serum

172

1.19

0.28

1.0

0.08

0.90

u/ml

0.76

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

275

2572

1.04

0.28

1.6

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

147

0.80

0.27

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

236

1.16

0.27

1.3

1.4

43.05

71.15

mu/l

0.82

191

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

458

1.11

0.27

1.3

1.2

21.82

20.35

0.05

(3028717) Thiamine [Mass/volume] in Blood

218

1.16

0.27

1.2

59.19

60.89

ug/l

0.24

218

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

617

1.09

0.27

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

273

1.14

0.27

1.5

1.4

5.42

5.47

mmol/l

0.13

273

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1141

10918

1.02

0.27

1.4

1.5

1.18

1.16

ratio

0.16

653

6525

(3020393) Adenovirus Ag [Presence] in Stool

101

1.26

0.27

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

324

0.87

0.27

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

440

1.11

0.27

1.4

1.3

6.20

5.63

nmol/l

0.49

417

(40757373) Influenza virus identified in Isolate

178

0.82

0.27

1.3

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

191

1954

0.95

0.26

1.4

1.5

6.91

7.28

mmol/l

1.16

185

1906

(3009677) Dengue virus Ab [Presence] in Serum

1.30

0.26

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

240

0.85

0.26

1.2

1.3

37.64

39.40

g/l

—

122

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1144

10955

1.02

0.26

1.4

1.5

1.16

1.19

ratio

0.38

661

6616

(3006245) CD3-CD19+ cells/cells in Blood

657

1.08

0.25

2.1

2.3

6.89

8.27

0.60

620

(3019420) Tryptase [Mass/volume] in Serum or Plasma

110

1142

0.94

0.25

1.9

1.4

9.72

6.86

ug/l

0.43

103

1028

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

762

7595

0.98

0.25

1.2

1.1

0.86

0.87

g/l

0.26

757

7583

(3000285) Sodium [Moles/volume] in Blood

134

0.80

0.24

1.0

1.2

139.45

138.66

mmol/l

0.61

107

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

168

1720

0.95

0.24

3.6

3.5

177.35

593.09

u/ml

1.32

155

1540

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1143

10955

1.02

0.24

1.4

1.5

0.97

0.95

ratio

0.69

655

6562

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

584

1.09

0.24

1.4

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

112

1.22

0.23

1.1

1.2

1.52

1.87

mmol/l

—

(3017704) Immunofixation for Urine

342

1.11

0.23

2.5

1.6

—

(40768795) Lymph node Pathology biopsy report

128

1182

1.06

0.23

1.1

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

189

1764

1.05

0.23

1.1

—

62.64

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

718

1.07

0.23

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

122

0.80

0.23

1.3

1.4

1.70

3.29

—

103

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

175

1785

0.96

0.23

4.6

4.8

76.44

110.83

u/ml

0.40

632

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

257

0.87

0.22

1.5

1.4

35.43

46.68

0.65

169

(3004775) Volume in Urine collected for unspecified duration

522

0.92

0.22

2.7

2.3

568.24

612.13

0.47

406

(3022229) Phosphate [Moles/volume] in Urine

1.22

0.22

1.0

1.3

18.90

13.17

mmol/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

162

1509

1.05

0.22

1.2

1.1

24.28

15.92

u/ml

0.98

689

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

122

1128

1.06

0.22

1.0

1.1

0.95

1.10

u/l

4.43

428

(3010015) Selenium [Moles/volume] in Serum or Plasma

215

0.86

0.21

1.8

1.32

1.33

umol/l

0.02

163

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

297

0.89

0.21

1.1

—

215.38

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.19

0.21

4.4

6.7

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

4.8

—

2.65

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

132

1.18

0.21

1.0

0.37

0.07

u/ml

0.67

132

(3044927) Protein electrophoresis panel - Urine

646

1.07

0.21

1.1

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

684

1.07

0.20

1.6

1.7

4480.00

3162.00

titre

—

110

(3044316) Mercury [Moles/volume] in Urine

0.00

0.20

0.0

1.5

—

6.42

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

0.00

0.20

0.0

1.3

—

0.50

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

255

0.88

0.20

1.0

0.59

0.14

u/ml

0.63

141

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

274

2760

0.97

0.20

1.4

1.5

6.96

6.66

mmol/l

0.93

256

2517

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2219

21859

0.99

0.20

1.7

1.8

3.28

3.26

ratio

0.36

1607

15836

(3037692) Legionella sp identified in Specimen by Organism specific culture

308

1.11

0.20

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.24

0.20

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

361

3424

1.03

0.20

4.8

4.7

0.85

0.90

2.08

342

3232

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

203

0.86

0.20

1.0

1.10

0.04

u/ml

0.47

132

(3051101) Glucose [Moles/volume] in Cord blood

108

0.81

0.20

1.9

4.4

8.79

7.92

mmol/l

—

108

(3029396) Erythrocyte agglutination [Presence] in Blood

105

1080

0.95

0.20

3.0

3.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

111

1029

1.05

0.19

1.6

2.24

2.21

u/ml

0.01

237

(4133840) Spirometry

294

0.90

0.19

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

161

1.15

0.19

1.1

—

0.77

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

253

0.89

0.19

1.1

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

206

1940

1.04

0.18

4.3

2.8

4.92

4.99

kpa

0.78

201

1903

(3012501) Base excess in Blood by calculation

206

1940

1.04

0.18

4.3

2.8

2.10

2.35

mmol/l

0.57

122

1215

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

860

1.05

0.18

1.5

1.4

4.66

5.20

u/l

1.29

740

(3015076) Soybean IgE Ab [Units/volume] in Serum

143

1338

1.04

0.17

1.0

0.49

0.36

u/ml

0.17

277

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

330

1.09

0.17

1.5

1.7

—

382.50

iu/ml

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

805

0.94

0.17

1.8

1.7

2.00

1.94

umol/l

0.34

734

(3045142) Bone marrow Pathology biopsy report

880

1.05

0.17

1.4

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

131

1224

1.04

0.17

1.8

1.7

48.18

47.91

0.03

749

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

313

2973

1.03

0.17

1.3

1.2

4.86

2.94

u/ml

0.39

123

1094

(3008536) Aspergillus sp Ab [Presence] in Serum

181

1.13

0.17

3.0

2.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

403

0.92

0.17

3.3

3.0

29.94

27.82

umol/l

0.79

308

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1124

10819

1.01

0.17

1.4

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.76

0.17

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

138

0.85

0.17

1.4

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

372

0.92

0.16

2.8

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

543

0.93

0.16

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

275

1.10

0.16

2.7

2.0

424.52

843.37

e6/l

1.27

168

(37208534) Antinuclear antibody arbitrary concentration in serum

573

0.94

0.16

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

113

1054

1.05

0.16

1.6

1.5

1.55

1.51

nmol/l

0.12

106

941

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

139

1303

1.04

0.16

1.2

28.99

26.87

u/l

0.08

121

1143

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

816

1.05

0.16

2.0

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

816

1.05

0.16

2.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

816

1.05

0.16

2.0

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

903

8684

1.01

0.16

3.7

3.3

1.23

mmol/l

1.73

776

7492

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

208

1967

1.03

0.16

1.2

1.1

94.59

94.58

0.00

196

1850

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

721

0.95

0.15

1.1

1.2

60.87

69.31

ug/l

0.95

721

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

160

1507

1.04

0.15

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

217

2055

1.03

0.15

1.2

1.3

—

18.46

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

437

1.07

0.15

1.0

1.30

0.81

u/ml

0.31

367

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

495

4915

0.98

0.15

1.1

2.42

2.01

u/ml

0.42

251

2494

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

968

0.96

0.14

1.1

1.2

21.64

12.16

u/ml

0.23

120

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1194

11518

1.01

0.14

1.5

63.65

62.10

ug/l

0.36

973

9515

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

156

0.87

0.14

1.0

3.40

5.56

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

429

4106

1.02

0.14

1.1

1.66

1.61

u/ml

0.04

188

1975

(3006270) Folate [Moles/volume] in Blood

917

0.96

0.14

1.1

407.73

402.42

nmol/l

0.09

852

(3005082) Progesterone [Moles/volume] in Serum or Plasma

241

2410

0.97

0.14

1.4

1.5

32.75

34.29

nmol/l

0.35

227

2221

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

206

1954

1.03

0.14

1.2

1.3

0.52

2.26

nmol/l

0.95

199

1892

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

166

0.88

0.14

1.6

1.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

293

2922

0.98

0.13

3.6

3.9

34.97

32.27

u/ml

0.16

276

2816

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

907

1.04

0.13

1.1

0.23

7.36

nmol/l

2.03

147

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.81

0.13

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

195

1955

0.97

0.13

3.8

3.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

886

0.96

0.13

1.3

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

206

1956

1.03

0.13

4.3

2.9

9.04

8.98

kpa

0.19

201

1919

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

107

0.82

0.13

1.2

1.4

—

(3005570) Glucose [Moles/volume] in Urine

127

1198

1.03

0.12

1.8

2.0

—

0.63

—

(3007700) Barley IgE Ab [Units/volume] in Serum

120

1.14

0.12

1.0

0.07

13.05

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

623

1.05

0.12

1.3

1.4

8243.92

2369.94

e6/l

0.50

432

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

671

1.05

0.12

1.5

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

233

1.09

0.12

1.0

1.1

0.21

8.88

u/ml

0.52

103

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

405

0.94

0.11

2.8

2.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

1.13

0.11

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

102

960

1.04

0.11

2.5

2.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

524

0.95

0.11

2.3

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

214

0.91

0.11

1.2

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

198

1885

1.02

0.11

2.7

2.2

16.88

16.85

0.05

192

1850

(3014271) Vancomycin [Susceptibility]

234

1.08

0.11

2.2

2.9

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

324

0.93

0.11

1.1

1.0

73.28

75.19

ug/l

0.10

276

(3014599) Egg white IgE Ab [Units/volume] in Serum

143

1434

0.97

0.11

1.0

0.76

1.85

u/ml

0.85

326

(3040151) Glucose [Moles/volume] in Capillary blood

116

1096

1.03

0.11

5.0

3.6

6.49

7.04

mmol/l

0.81

903

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

885

1.04

0.10

3.5

2.8

941.80

808.23

u/ml

0.19

879

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.16

0.10

1.4

1.1

—

(3024263) Appearance of Synovial fluid

473

0.95

0.10

2.0

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

197

1.09

0.10

1.0

1.1

0.03

0.06

u/ml

0.94

197

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

128

1213

1.03

0.10

1.3

1019.05

1068.24

titre

0.15

255

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

522

0.95

0.10

2.3

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

522

0.95

0.10

2.3

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

522

0.95

0.10

2.3

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

656

1.04

0.10

1.2

1.1

69.28

57.14

u/ml

0.74

647

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

442

0.95

0.10

1.1

—

(3045788) Cell count panel - Pleural fluid

522

1.05

0.10

1.4

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

172

0.91

0.09

1.0

0.51

0.46

u/ml

0.04

159

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.08

0.09

1.2

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

160

1.10

0.09

1.9

1.19

1.20

mmol/l

0.45

153

(3016031) Almond IgE Ab [Units/volume] in Serum

179

1.09

0.09

1.1

1.0

0.26

0.29

u/ml

0.04

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

513

1.05

0.09

2.6

2.5

50.66

47.96

umol/l

0.26

449

(3014133) Dog dander IgE Ab [Units/volume] in Serum

383

3682

1.01

0.09

1.1

4.07

4.06

u/ml

0.00

176

1745

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

352

3382

1.02

0.09

1.1

13.67

14.92

au/ml

0.15

101

1034

(3017315) Amylase [Enzymatic activity/volume] in Urine

638

1.04

0.09

1.3

168.13

243.98

u/l

1.67

597

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

229

2274

0.98

0.09

1.1

94.39

5117.95

iu/ml

0.63

527

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.13

0.09

1.2

1.1

123.50

263.49

u/l

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.10

0.09

1.2

24.83

29.11

mg/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

161

0.91

0.09

1.2

1.1

—

(21494434) Karyotype in Bone marrow

639

1.04

0.09

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

793

1.03

0.08

1.8

3.13

2.02

u/field

0.64

454

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

361

1.05

0.08

1.0

16.07

7.37

u/ml

0.42

361

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

142

1.10

0.08

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

717

1.03

0.08

1.2

104.76

110.56

0.92

655

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

114

1.11

0.08

1.7

—

(40768806) Pleura Pathology biopsy report

538

0.96

0.08

1.4

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.13

0.08

1.2

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

622

1.03

0.07

1.2

1.4

14.44

20.95

u/ml

—

105

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.84

0.07

2.5

3.3

—

0.00

estimate

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.82

0.07

4.2

4.8

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

0.81

0.07

1.0

1.2

—

23.05

—

(3003434) Protein [Mass/volume] in Pleural fluid

685

0.97

0.07

1.4

35.14

34.82

g/l

0.07

632

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

535

5267

0.99

0.07

1.5

0.45

0.47

nmol/l

0.16

437

4187

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

324

3120

1.01

0.07

1.0

1.1

0.11

0.22

u/ml

0.97

894

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

368

0.95

0.07

2.8

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

368

0.95

0.07

2.8

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

191

1.07

0.07

1.8

1.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.83

0.07

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.82

0.07

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

129

0.91

0.07

4.3

3.1

36.72

59.60

pmol/l

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

335

1.05

0.07

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

335

1.05

0.07

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

335

1.05

0.07

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

335

1.05

0.07

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

782

0.97

0.07

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

173

1716

0.98

0.07

2.8

2.4

58.36

69.69

ug/min

0.25

108

1065

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

364

1.04

0.06

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

364

1.04

0.06

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

364

1.04

0.06

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.87

0.06

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

526

5174

0.99

0.06

1.1

5.42

4.56

eliau/ml

0.15

794

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

122

1166

1.02

0.06

1.4

1.5

5.37

5.25

mmol/l

0.78

115

1116

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

173

1.07

0.06

1.4

1.6

—

(3004451) EKG impression Narrative

365

1.04

0.06

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

146

1399

1.02

0.06

1.8

1.7

1.56

1.67

mmol/l

0.85

140

1365

(40758292) HTLV I+II Ab panel - Serum

221

1.06

0.06

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

731

0.97

0.06

1.2

78.17

71.83

u/l

0.56

668

(3009214) Lutropin [Units/volume] in Serum or Plasma

620

6006

1.01

0.05

1.2

1.3

12.33

12.38

u/l

0.03

514

4957

(3027923) C peptide [Moles/volume] in Serum or Plasma

627

1.03

0.05

1.6

2.1

1.29

1.36

nmol/l

0.21

492

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

286

2817

0.99

0.05

2.2

1.9

2.74

1.73

ug/l

0.56

247

2501

(3016750) Collection duration of Urine

415

1.03

0.05

2.7

2.2

502.24

507.08

min

0.16

342

(3044007) Cell count panel - Peritoneal fluid

246

0.95

0.05

3.0

1.9

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

358

1.04

0.04

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

284

2745

1.01

0.04

1.1

—

(1616796) Gas panel - Central venous blood

222

2143

1.01

0.04

4.0

2.8

—

(3000012) Reticulocyte production index

950

1.02

0.04

1.8

1.9

0.97

0.89

0.37

546

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

185

1823

0.99

0.04

1.3

2502.97

1193.75

pmol/l

0.26

140

(3022475) Manganese [Moles/volume] in Blood

116

0.92

0.03

1.0

1.2

0.17

0.16

umol/l

0.45

116

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

131

1261

1.01

0.03

1.2

1.1

1.07

1.05

ratio

0.49

106

1052

(3002079) Sodium [Moles/time] in 24 hour Urine

718

1.02

0.03

1.3

146.01

142.70

mmol/24h

0.18

718

(3008401) Mugwort IgE Ab [Units/volume] in Serum

413

4048

0.99

0.03

1.1

1.14

0.93

u/ml

0.26

163

1688

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

477

1.02

0.03

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

257

2523

0.99

0.03

2.1

2.0

4.96

5.31

mmol/24h

1.19

244

2309

(3006442) Creatine [Moles/volume] in Serum or Plasma

831

0.99

0.02

1.5

1.4

67.19

68.68

umol/l

0.40

831

(4146454) Self-monitoring of blood glucose

750

1.01

0.02

2.5

2.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

527

1.02

0.02

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

305

2988

1.00

0.02

1.1

2.92

2.78

eliau/ml

0.09

171

1597

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

751

1.01

0.02

1.4

1.2

56.08

67.66

0.58

(3028308) Erythrocytes [#/volume] in Pleural fluid

547

1.02

0.02

1.3

1.4

41838.97

51296.33

e6/l

0.14

280

(3003329) Lymphocytes/Leukocytes in Synovial fluid

917

1.01

0.01

1.7

1.6

37.40

40.68

0.36

551

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2530

24694

1.00

0.01

1.6

43427460.71

39651931.26

pmol/l

0.12

2206

21578

(3002331) Protein [Mass/volume] in Peritoneal fluid

159

1.04

0.01

1.1

1.5

13.36

26.46

g/l

—

119

(3034988) Calcium [Moles/volume] in Capillary blood

159

1.04

0.01

1.9

1.17

1.19

mmol/l

0.67

150

(3001186) Copper [Moles/volume] in Serum or Plasma

446

0.98

0.01

1.4

1.5

18.39

17.32

umol/l

0.86

375

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

581

5654

1.00

0.01

1.4

1.3

3.28

3.11

ug/l

0.12

530

5180

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

348

0.98

0.01

2.8

2.9

1.30

1.42

0.09

348

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

113

0.95

0.00

1.1

9.47

29.19

pmol/l

0.61

113

(3017446) Testosterone [Moles/volume] in Serum or Plasma

261

2538

1.00

0.00

1.4

1.44

1.54

nmol/l

0.38

234

2165

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

238

1.02

0.00

2.7

1.8

956.86

18937.78

e6/l

1.04

100

(44806071) Cardiolipin IgM antibody measurement

277

1.02

0.00

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

727

0.99

0.00

1.1

1.2

21.14

16.11

u/l

0.64

665

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

180

1.03

0.00

1.6

2.2

6.32

8.73

ug/l

0.38

180

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

212

1.01

0.00

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

325

0.99

0.00

4.4

4.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

187

1823

1.00

0.00

1.7

1.6

37.13

31.13

ng/l

0.31

187

1817

(3020874) Milk IgE Ab [Units/volume] in Serum

152

1477

1.00

0.00

1.0

1.1

0.36

1.34

u/ml

2.61

438

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1.00

0.00

2.0

1.8

42.15

41.23

g/l

0.57

313

(3023430) Cat dander IgE Ab [Units/volume] in Serum

361

3517

1.00

0.00

1.1

3.00

4.36

u/ml

1.41

145

1513

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

165

1608

1.00

0.00

4.5

4.4

43.58

47.48

u/ml

0.12

165

1602

(3005011) Chlamydia sp Ab [Titer] in Serum

230

1.02

0.00

1.4

1.6

—

(3035880) pH of Pleural fluid

262

1.00

0.00

1.0

1.2

7.46

7.43

0.66

167

(40762365) Oxygen content in Arterial blood by calculation

1.04

0.00

3.4

1.9

14.64

14.66

ml/dl

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

715

1.00

0.00

1.5

1.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

388

1.01

0.00

1.1

3.23

1.04

u/ml

0.40

241

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

297

2891

1.00

0.00

1.3

4.29

4.08

u/ml

0.04

143

1284

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

129

0.98

0.00

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

436

4250

1.00

0.00

1.1

5.23

4.57

u/ml

0.42

217

2201

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

106

1.01

0.00

1.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

394

0.99

0.00

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

698

1.01

0.00

1.5

1.4

78.61

172.84

nmol/24h

1.12

698

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.89

-0.00

1.1

0.02

0.05

mg/l

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.92

-0.00

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3006906) Calcium [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

2.44

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.95

-0.00

1.4

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.1

—

15.00

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

0.55

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.67

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

139.14

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.01

-0.00

1.8

1.7

306.78

310.09

umol/24h

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.99

-0.00

1.4

1.3

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.01

-0.00

1.0

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

301.75

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.89

-0.00

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.99

-0.00

1.0

—

(3006598) pH of Arterial cord blood

1.01

-0.00

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.92

-0.00

2.3

2.2

51.00

47.36

umol/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.09

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.98

-0.00

1.2

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.99

-0.00

1.4

1.7

83.40

337.06

nmol/l

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

0.93

-0.00

1.0

1.4

83.67

67.80

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_FEMALE_GENITAL_DYSPLASIA_ALL and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_FEMALE_GENITAL_DYSPLASIA_ALL	1.196 [1.08, 1.33]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.073

During the follow-up period (1.1.1998 — 31.12.2019), 2759 out of 68239 females with N14_FEMALE_GENITAL_DYSPLASIA_ALL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_FEMALE_GENITAL_DYSPLASIA_ALL.

N-year risk	Females	Males
1	0.13%	No data
5	0.683%	No data
10	1.712%	No data
15	3.213%	No data
20	5.647%	No data

Relationships between endpoints

↥

Index endpoint: N14_FEMALE_GENITAL_DYSPLASIA_ALL – All dysplastic lesions of the cervix uteri, vagina or vulva

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

All dysplastic lesions of the cervix uteri, vagina or vulva

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints